Other infective otitis externa

H8_EXT_INFNAS

otitis externa: Inflammation of the anatomical structures of the outer ear and ear canal secondary to an infectious process. Bacterial etiology is most common, but fungal infection is also possible. Symptoms include erythema, edema, and pain.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H60.3 Cause of death: ICD-10 — H60.3 2 out of 7 registries used, show all original rules.	2800
4. Check minimum number of events None	2800
5. Include endpoints None	2800
6. Filter based on genotype QC (FinnGen only)	2500

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H60
Name in latin: Alia otitis externa infectiosa

NAME	H8_EXT_INFNAS
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H603
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H603
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other infective otitis externa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	16526	8526	7935
Only index persons	15476	8098	7378
Unadjusted period prevalence (%)
Whole population	0.23	0.24	0.22
Only index persons	0.29	0.30	0.28
Median age at first event (years)
Whole population	46.95	45.50	48.53
Only index persons	47.01	45.65	48.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2500	1409	1091
Unadjusted period prevalence (%)	0.50	0.50	0.50
Median age at first event (years)	53.66	49.44	59.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2612: Matched controls
26120

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H60.3

ICD-10 Finland

Other infective otitis externa

+∞

307.7

2612

125

H60

ICD-10 Finland

Otitis externa

10.2

307.7

518

616

H60.8

ICD-10 Finland

Other otitis externa

36.5

307.7

569

198

H60.9

ICD-10 Finland

Otitis externa, unspecified

19.2

307.7

1006

827

H70

ICPC

Otitis externa

15.8

299.1

266

186

H66.0

ICD-10 Finland

Acute suppurative otitis media

6.2

278.2

546

1060

H01

ICPC

Ear pain/earache

5.0

261.6

700

1783

UDC00

NOMESCO Finland

Ear microscopy

6.4

260.5

493

921

H61.2

ICD-10 Finland

Impacted cerumen

7.2

259.5

425

685

H66.9

ICD-10 Finland

Otitis media, unspecified

6.4

255.0

478

884

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

15.7

240.5

213

147

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

29.5

228.7

153

H60.1

ICD-10 Finland

Cellulitis of external ear

20.4

208.3

161

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

10.3

204.4

237

250

H29

ICPC

Ear symptom/complaint other

4.3

198.3

630

1803

H04

ICPC

Ear discharge

8.1

187.4

265

359

Z01.1

ICD-10 Finland

Examination of ears and hearing

3.9

183.8

678

2149

DC1AD

NOMESCO Finland

Temporalbone CT

19.9

174.5

136

DFF00

NOMESCO Finland

Pure tone audiometry

4.3

169.4

517

1424

H61.8

ICD-10 Finland

Other specified disorders of external ear

33.1

167.9

108

H60.0

ICD-10 Finland

Abscess of external ear

34.2

160.2

102

H65.3

ICD-10 Finland

Chronic mucoid otitis media

9.7

160.1

192

211

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

25.6

154.0

108

H71

ICD-10 Finland

Cholesteatoma of middle ear

17.3

149.2

124

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

33.6

142.3

S02CA02

ATC

flumetasone and antiinfectives; otic

5.1

132.9

300

644

H92.0

ICD-10 Finland

Otalgia

4.4

124.5

340

851

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

9.8

123.1

145

155

H70.1

ICD-10 Finland

Chronic mastoiditis

47.2

117.7

TDA90

NOMESCO Finland

Removal wax from ear

12.6

111.9

111

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

5.9

110.6

208

377

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.2

98.1

284

739

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

7.2

97.5

148

215

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

8.8

97.1

124

147

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.8

96.8

605

2538

H65.2

ICD-10 Finland

Chronic serous otitis media

9.7

92.1

109

117

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.3

91.0

1610

10706

J01MA02

ATC

ciprofloxacin; systemic

2.3

90.0

1198

7073

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

14.0

89.8

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.3

87.2

238

591

Z97.4

ICD-10 Finland

Presence of external hearing-aid

4.5

85.5

222

530

J01DB01

ATC

cefalexin; oral

3.4

85.5

2338

18703

H13

ICPC

Plugged feeling ear

2.5

83.0

663

3114

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.7

71.1

456

1912

D07AB02

ATC

hydrocortisone butyrate; topical

2.1

67.6

908

5235

Z2221

NOMESCO Finland

Medical doctor

2.1

64.8

835

4724

H65.0

ICD-10 Finland

Acute serous otitis media

6.3

64.1

109

178

J01DA01

ATC

[U] cefalexin

2.0

60.8

1704

12600

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

5.2

59.9

125

248

H81

ICPC

Excessive ear wax

2.3

59.7

548

2694

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

59.5

295

1075

D07AC01

ATC

betamethasone; topical

2.0

59.4

1061

6710

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.3

56.3

531

2634

R5120

NOMESCO Finland

Preparation of an aid

4.5

54.4

138

322

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

6.9

53.5

123

DFF15

NOMESCO Finland

Speech audiometry

3.5

52.9

191

574

H66

ICD-10 Finland

Suppurative and unspecified otitis media

4.8

52.8

122

264

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

52.7

1303

9063

DAX08

NOMESCO Finland

Fitting of hearing aid

3.3

51.6

208

670

J01FF01

ATC

clindamycin; systemic

2.0

51.6

796

4737

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

51.6

574

3032

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

17.8

51.6

Z71.8

ICD-10 Finland

Other specified counselling

1.9

49.4

1006

6542

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

49.4

887

5539

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

48.7

645

3626

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.1

48.7

137

346

H02AB06

ATC

prednisolone; systemic

1.8

48.7

1307

9246

E0000UV, ,

ATC

1.8

48.3

1170

8017

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

47.7

796

4841

DCD00

NOMESCO Finland

Myringoplasty

9.7

46.9

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

46.7

364

1653

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

11.4

45.8

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

60.1

45.5

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

9.0

44.6

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

17.0

44.5

R01AD09

ATC

mometasone; nasal

1.8

44.2

1263

9010

Z3226

NOMESCO Finland

Physiotherapist

2.1

44.1

540

2939

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

43.5

808

5060

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

14.0

43.4

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

43.3

430

2159

H74.1

ICD-10 Finland

Adhesive middle ear disease

16.9

41.9

H02AB07

ATC

prednisone; oral

2.2

41.7

401

1985

J01CA04

ATC

amoxicillin; systemic

2.1

41.6

2192

18655

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

40.7

1014

6906

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

15.4

40.0

N02AX02

ATC

tramadol; systemic, rectal

1.7

39.2

1149

8165

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

7.7

39.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

38.9

709

4386

J01FA10

ATC

azithromycin; systemic

1.7

38.4

1540

11896

R01AD08

ATC

fluticasone; nasal

1.8

37.5

790

5096

Z3231

NOMESCO Finland

Registered nurse

1.8

37.2

741

4700

H60.4

ICD-10 Finland

Cholesteatoma of external ear

62.4

37.2

J01DA06

ATC

[U] cefuroxime

2.1

37.2

418

2192

D07XC01

ATC

betamethasone; topical

2.2

37.2

358

1769

R4110

NOMESCO Finland

Physiotherapy

1.8

37.0

762

4882

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

36.4

982

6784

A46

ICD-10 Finland

Erysipelas

2.1

36.0

414

2188

R03AC02

ATC

salbutamol; inhalant

1.7

35.3

1465

11308

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

35.1

1462

11289

J01MA12

ATC

levofloxacin; systemic

1.9

35.0

509

2916

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

5.5

34.8

127

A02BC02

ATC

pantoprazole; systemic

1.7

34.8

1785

14542

J01FA09

ATC

clarithromycin; systemic

1.7

34.7

836

5581

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

33.7

1119

8119

S29

ICPC

Skin symptom/complaint other

1.8

33.5

576

3479

R74

ICPC

Upper respiratory infection acute

1.7

33.1

906

6245

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

32.8

425

2337

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.6

32.4

110

317

R06AE07

ATC

cetirizine; oral

1.6

32.3

1156

8520

L17

ICPC

Foot/toe symptom/complaint

1.7

31.7

832

5656

M79.6

ICD-10 Finland

Pain in limb

1.6

31.7

1164

8623

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

31.6

689

4451

RK320, ,

NOMESCO Finland

7.7

31.5

H71

ICPC

Acute otitis media/myringitis

5.6

31.3

110

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

53.6

31.3

D07AC13

ATC

mometasone; topical

1.7

30.9

761

5079

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

30.8

1138

8424

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.0

30.7

381

2061

J01DA09

ATC

[U] cefadroxil

1.7

30.4

702

4600

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

30.4

1142

8480

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

30.0

240

1095

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

29.9

262

1241

J02AC01

ATC

fluconazole; systemic

1.6

29.6

1003

7250

R42

ICD-10 Finland

Dizziness and giddiness

1.8

29.4

599

3785

ZXA00

NOMESCO Finland

Right side

1.7

29.2

655

4252

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

28.7

638

4128

H02

ICPC

Hearing complaint

1.9

28.7

392

2188

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

28.6

735

4943

Z01.2

ICD-10 Finland

Dental examination

1.6

28.4

1236

9453

R51.80

ICD-10 Finland

Headache

1.8

28.0

448

2630

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

27.9

593

3787

G47.3

ICD-10 Finland

Sleep apnoea

1.7

27.8

621

4018

J01AA02

ATC

doxycycline; systemic

1.7

27.8

1964

16810

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

27.7

504

3076

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

27.3

735

4993

N03AX16

ATC

[U] pregabalin

1.7

27.2

593

3809

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

27.2

636

4165

P01AB01

ATC

metronidazole; oral, rectal

1.6

27.1

1021

7526

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

26.9

526

3275

N02BE01

ATC

paracetamol; systemic, rectal

2.0

26.8

2311

20790

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

46.2

26.5

T16

ICD-10 Finland

Foreign body in ear

5.8

26.3

AA1AD

NOMESCO Finland

CT of head and brain

1.6

26.3

721

4912

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

26.3

1198

9202

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

26.2

525

3289

D07AD01

ATC

clobetasol; topical

1.8

26.1

444

2651

S76

ICPC

Skin infection other

2.5

26.1

168

694

R02

ICPC

Shortness of breath/dyspnoea

1.9

26.0

377

2141

ZXA05

NOMESCO Finland

Left side

1.7

25.9

596

3878

H61.9

ICD-10 Finland

Disorder of external ear, unspecified

9.8

25.9

J01DC02

ATC

cefuroxime; systemic

2.5

25.8

167

692

E000001, ,

ATC

1.7

25.8

522

3280

J20

ICD-10 Finland

Acute bronchitis

2.0

25.8

290

1511

R05

ICPC

Cough

1.7

25.6

673

4531

WX002

NOMESCO Finland

Sedation and analgesia

1.8

25.6

488

3014

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.8

25.5

128

466

H02AB04

ATC

methylprednisolone; systemic

1.9

25.3

374

2136

N07CA01

ATC

betahistine; oral

2.3

25.1

196

883

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

25.0

1317

10404

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

24.6

664

4494

T90

ICPC

Diabetes non-insulin dependent

1.7

24.5

612

4062

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

24.3

1860

15901

M25.5

ICD-10 Finland

Pain in joint

1.6

24.1

869

6296

A02BC05

ATC

esomeprazole; systemic

1.5

24.1

1012

7591

E66.8

ICD-10 Finland

Other obesity

2.4

23.9

175

767

S18

ICPC

Laceration/cut

1.5

23.4

1184

9225

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

23.0

104

358

D07AB08

ATC

desonide; topical

2.0

22.9

287

1550

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.7

22.7

129

501

L15

ICPC

Knee symptom/complaint

1.6

22.4

663

4574

RK110, ,

NOMESCO Finland

6.2

22.4

A97

ICPC

No disease

1.7

22.2

535

3508

ZXA10

NOMESCO Finland

Bilateral

1.7

22.0

448

2806

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

22.0

1848

15919

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

22.0

1440

11775

H51

ICPC

Ear, I&d/flush/aspiration

4.3

21.8

132

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

21.7

586

3952

M03BX02

ATC

tizanidine; oral

1.5

21.6

1550

12889

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

21.6

723

5127

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

21.4

283

1555

XG410

NOMESCO Finland

Flow-volume spirometry

2.7

21.3

119

459

D01

ICPC

Abdominal pain/cramps general

1.8

21.2

340

1986

J01FA06

ATC

roxithromycin; oral

1.5

21.2

964

7302

M54.5

ICD-10 Finland

Low back pain

1.5

20.9

931

7012

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

20.9

637

4416

Z01.7

ICD-10 Finland

Laboratory examination

1.7

20.3

444

2831

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

20.3

286

1604

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

20.3

571

3881

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

20.3

583

3983

L12

ICPC

Hand/finger symptom/complaint

1.7

20.2

457

2940

H73.1

ICD-10 Finland

Chronic myringitis

48.4

20.2

RK520, ,

NOMESCO Finland

8.5

20.1

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

20.1

325

1902

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

20.1

350

2094

SFA30

NOMESCO Finland

Three-surface restoration

1.5

20.1

1058

8229

ZXD20

NOMESCO Finland

Day surgery

1.8

20.0

327

1922

H60.2

ICD-10 Finland

Malignant otitis externa

58.0

19.9

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

19.9

312

1810

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

19.7

941

7172

A10BA02

ATC

metformin; oral

1.5

19.6

684

4878

K02.1

ICD-10 Finland

Caries of dentine

1.5

19.6

1501

12531

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

19.5

190

936

R60.0

ICD-10 Finland

Localized oedema

1.8

19.5

317

1858

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

40.4

19.5

A02BA02

ATC

ranitidine; systemic

1.7

19.4

455

2952

G44.2

ICD-10 Finland

Tension-type headache

1.7

19.2

356

2169

ZXE00

NOMESCO Finland

One hour or less

1.5

19.1

942

7210

N06AX11

ATC

mirtazapine; oral

1.5

19.1

837

6257

R53

ICD-10 Finland

Malaise and fatigue

1.6

19.0

637

4499

J01DC04

ATC

cefaclor; oral

4.2

18.9

121

D11

ICPC

Diarrhoea

1.8

18.9

322

1914

UJF32

NOMESCO Finland

Coloscopy

1.6

18.8

621

4370

A03

ICPC

Fever

1.6

18.7

454

2968

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

18.7

338

2043

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

5.1

18.6

S02CA06

ATC

dexamethasone and antiinfectives; otic

5.4

18.5

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

18.5

213

1115

D05AX52

ATC

calcipotriol, combinations; topical

2.3

18.4

145

656

R03BB04

ATC

tiotropium bromide; inhalant

1.9

18.3

253

1409

U07

ICPC

Urine symptom/complaint other

2.0

18.3

223

1191

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

18.2

189

953

K03.66

ICD-10 Finland

Tooth plaque

2.0

18.2

214

1129

N06AB10

ATC

escitalopram; oral

1.6

18.2

513

3479

R06.0

ICD-10 Finland

Dyspnoea

1.5

18.1

670

4826

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

5.4

18.1

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.3

18.0

141

636

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

18.0

234

1278

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

17.8

233

1274

D06AX01

ATC

fusidic acid; topical

1.9

17.7

241

1336

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

17.6

996

7796

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.9

17.6

253

1426

XQ802

NOMESCO Finland

Epicutan test

2.4

17.6

118

497

C03CA01

ATC

furosemide; systemic

1.5

17.5

652

4697

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

17.5

858

6535

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

17.5

350

2175

R06AX27

ATC

desloratadine; oral

1.5

17.4

721

5310

R03BA02

ATC

budesonide; inhalant

1.6

17.4

446

2953

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

17.4

250

1410

S02AA03

ATC

boric acid; otic

5.0

17.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

17.2

319

1939

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.8

17.2

289

1708

A04

ICPC

Weakness/tiredness general

1.6

17.2

404

2616

EBA00

NOMESCO Finland

Extraction of tooth

1.5

17.2

922

7140

L28

ICPC

Limited function/disability (L)

1.6

17.1

446

2962

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

17.0

566

3977

DEB30

NOMESCO Finland

Radical mastoidectomy

50.3

17.0

N05AH04

ATC

quetiapine; oral

1.6

16.9

441

2929

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

16.9

628

4517

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

4.4

16.9

N05BA01

ATC

diazepam; systemic, rectal

1.7

16.8

308

1865

XF402

NOMESCO Finland

ECG with work load test

1.8

16.8

252

1439

X58

ICD-10 Finland

Exposure to other specified factors

1.7

16.8

385

2477

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

35.3

16.7

R4120

NOMESCO Finland

Occupational therapy

2.0

16.6

175

887

M01AB05

ATC

diclofenac; systemic, rectal

1.4

16.6

1610

13832

N05BA04

ATC

oxazepam; oral

1.5

16.6

619

4455

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

16.4

16.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

16.5

122

537

SFA10

NOMESCO Finland

One-surface restoration

1.4

16.5

1375

11495

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

16.5

1676

14512

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

16.4

152

734

WX892

NOMESCO Finland

Monitored bed care

1.9

16.4

199

1061

XQ800

NOMESCO Finland

Prick test

2.0

16.3

196

1042

R5110, ,

SPAT

1.9

16.3

213

1165

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

16.3

238

1349

J34.2

ICD-10 Finland

Deviated nasal septum

2.2

16.3

146

697

K07.60

ICD-10 Finland

Snapping jaw

2.2

16.1

143

679

C07AB07

ATC

bisoprolol; oral

1.4

16.1

1117

9028

KMAK, ,

NOMESCO Finland

1.4

16.1

1242

10229

A01

ICPC

Pain general/multiple sites

1.8

16.0

258

1506

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

24.6

16.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

16.0

271

1606

M01AE02

ATC

naproxen; oral, rectal

1.4

15.9

1395

11731

C08CA01

ATC

amlodipine; oral

1.4

15.9

865

6694

ZXD05

NOMESCO Finland

Urgent procedure

1.5

15.8

717

5357

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

15.8

832

6395

Z2446

NOMESCO Finland

Social worker

2.0

15.8

176

911

A10AE04

ATC

insulin glargine; parenteral

1.8

15.8

240

1376

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

15.7

446

3019

-60

ICPC

Result test/procedure

2.1

15.7

145

700

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

13.0

15.6

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

15.6

466

3189

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

15.6

256

1502

WX722

NOMESCO Finland

PEEP

2.3

15.5

122

552

N30.0

ICD-10 Finland

Acute cystitis

1.6

15.4

411

2741

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.4

15.4

111

484

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.3

238

1373

J01MA01

ATC

ofloxacin; systemic

1.9

15.3

197

1072

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

15.2

451

3081

B01AB05

ATC

enoxaparin; parenteral

1.5

15.2

729

5499

A28

ICPC

Limited function/disability NOS

1.6

15.2

394

2609

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

15.2

254

1498

F29

ICPC

Eye symptom/complaint other

1.7

15.1

271

1631

H27

ICPC

Fear of ear disease

3.9

15.0

115

N06AB04

ATC

citalopram; systemic

1.5

15.0

477

3309

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

14.9

317

1996

J02AC02

ATC

itraconazole; systemic

1.6

14.9

413

2777

R21

ICPC

Throat symptom/complaint

1.5

14.9

529

3757

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

14.9

380

2506

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

14.9

728

5510

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

14.8

465

3218

DCD10

NOMESCO Finland

Tympanoplasty

16.6

14.8

N02BF02

ATC

pregabalin; oral

1.9

14.7

178

948

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

14.7

1005

8065

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

14.6

1676

14650

WX290

NOMESCO Finland

Other blockage of nerve

1.4

14.6

1187

9803

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

14.5

283

1742

N06AX16

ATC

venlafaxine; oral

1.6

14.5

349

2269

A07AA02

ATC

nystatin; oral

2.1

14.5

140

688

EMB10

NOMESCO Finland

Tonsillectomy

2.1

14.4

143

709

L01

ICPC

Neck symptom/complaint

1.6

14.4

407

2747

R05

ICD-10 Finland

Cough

1.5

14.4

526

3754

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

14.4

722

5481

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

14.4

145

724

R03BA05

ATC

fluticasone; inhalant

1.5

14.4

440

3025

D19

ICPC

Teeth/gum symptom/complaint

1.4

14.3

762

5847

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

14.3

179

964

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

14.3

115

525

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.9

14.3

110

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

14.3

308

1946

H73.0

ICD-10 Finland

Acute myringitis

5.6

14.3

J37.0

ICD-10 Finland

Chronic laryngitis

2.5

14.3

375

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

14.2

231

1350

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

14.2

179

966

E000006, ,

ATC

2.0

14.2

158

817

D01AE15

ATC

terbinafine; topical

1.9

14.2

169

895

J01CF05

ATC

flucloxacillin; systemic

1.9

14.2

192

1061

N06AX21

ATC

duloxetine; oral

1.7

14.2

296

1855

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

14.2

968

7755

T78.4

ICD-10 Finland

Allergy, unspecified

2.2

14.1

120

561

L03

ICPC

Low back symptom/complaint

1.4

14.0

719

5477

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

14.0

520

3722

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

14.0

2280

21189

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

14.0

363

2401

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

14.0

141

704

J01FA01

ATC

erythromycin; systemic

1.6

13.9

326

2103

R01AD58

ATC

fluticasone, combinations; nasal

1.5

13.9

614

4546

R52.9

ICD-10 Finland

Pain, unspecified

1.7

13.9

257

1560

R83

ICPC

Respiratory infection other

1.5

13.8

625

4649

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

13.8

311

1987

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

13.8

625

4652

H70.0

ICD-10 Finland

Acute mastoiditis

20.1

13.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

13.8

654

4910

D07AA02

ATC

hydrocortisone; topical

1.6

13.7

330

2145

H25.8

ICD-10 Finland

Other senile cataract

1.8

13.7

229

1351

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

13.6

194

1090

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

13.6

584

4300

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

13.6

105

472

H62.2*B44.8

ICD-10 Finland

Otitis externa in aspergillosis

+∞

13.5

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.9

13.5

183

1011

R03DC03

ATC

montelukast; oral

1.5

13.5

404

2759

J01DA08

ATC

[U] cefaclor

1.7

13.5

276

1719

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

13.5

555

4051

A02BC01

ATC

omeprazole; systemic

1.4

13.5

615

4580

A11

ICPC

Chest pain NOS

1.8

13.4

211

1221

H62.0

ICD-10 Finland

Otitis externa in bacterial diseases classified elsewhere

21.3

13.3

SDA03

NOMESCO Finland

Periodontal treatment

1.4

13.3

983

7956

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

3.3

13.3

155

L16

ICPC

Ankle symptom/complaint

1.6

13.3

304

1950

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

13.3

228

1355

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

13.3

588

4354

R07.3

ICD-10 Finland

Other chest pain

1.7

13.2

254

1556

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

13.1

396

2710

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

13.1

119

571

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

13.1

441

SFA20

NOMESCO Finland

Two-surface restoration

1.4

13.0

1434

12338

Z00.0

ICD-10 Finland

General medical examination

1.5

13.0

458

3237

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

13.0

518

3755

H81.0

ICD-10 Finland

Ménière disease

2.8

13.0

232

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

13.0

313

2033

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

12.9

409

2828

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.3

12.9

400

S21

ICPC

Skin texture symptom/complaint

1.6

12.8

366

2473

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

12.8

229

1376

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

12.8

206

1201

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

12.7

818

6458

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

12.7

285

1819

M79.1

ICD-10 Finland

Myalgia

1.6

12.7

366

2479

E66

ICD-10 Finland

Obesity

2.0

12.6

147

773

M01AH05

ATC

etoricoxib; oral

1.4

12.6

1504

13073

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

12.6

300

1943

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.0

12.6

192

A08

ICPC

Swelling

2.0

12.6

143

746

H70.9

ICD-10 Finland

Mastoiditis, unspecified

32.2

12.6

UKC02

NOMESCO Finland

Cystoscopy

1.6

12.5

355

2394

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

12.5

242

1485

3801A

ICD-9 Finland

Disorders of external ear, Infective otitis externa[OTITIS EXTERNA ACUTA DIFFUSA]

+∞

12.5

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

12.5

253

1573

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

12.4

301

1956

ZXD35

NOMESCO Finland

Usual procedure

2.4

12.4

344

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

12.4

244

1504

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

12.4

906

7298

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

12.3

412

2879

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.6

12.3

262

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

12.2

357

2425

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

12.2

185

1060

N05CF01

ATC

zopiclone; oral

1.4

12.1

711

5524

H3603, E103,

ICD-10 Finland

4.1

12.0

S02

ICPC

Pruritus

2.3

11.9

420

4122

FHL

Tympanostomy (tympanic tube)

3.4

11.9

125

H81.3

ICD-10 Finland

Other peripheral vertigo

2.6

11.9

278

ZXC10

NOMESCO Finland

Use of laser

2.7

11.9

226

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

11.9

221

1343

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

11.8

173

980

R51

ICD-10 Finland

Headache

1.9

11.8

140

741

DAB00

NOMESCO Finland

Excision of lesion of auricle

4.2

11.8

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

11.8

236

1462

H03AA01

ATC

levothyroxine sodium; systemic

1.4

11.7

518

3825

DEB00

NOMESCO Finland

Cortical mastoidectomy

30.2

11.6

R01AD12

ATC

fluticasone furoate; nasal

1.4

11.6

753

5938

S04

ICPC

Lump/swelling localized

1.6

11.6

271

1746

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

11.6

138

732

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.2

11.5

452

R68.2

ICD-10 Finland

Dry mouth, unspecified

5.3

11.5

R03AC12

ATC

salmeterol; inhalant

2.1

11.5

103

492

L13

ICPC

Hip symptom/complaint

1.5

11.5

443

3183

N17

ICPC

Vertigo/dizziness

1.6

11.5

298

1968

A02BC03

ATC

lansoprazole; oral

1.4

11.5

635

4875

K11.2

ICD-10 Finland

Sialoadenitis

2.3

11.5

357

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

11.4

413

2931

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

11.4

339

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

11.4

435

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

11.4

164

925

A01AB09

ATC

miconazole; local oral

1.8

11.4

187

1097

R06AX22

ATC

ebastine; oral

1.5

11.4

399

2814

N03AX09

ATC

lamotrigine; oral

2.0

11.4

121

617

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

11.3

552

4144

S97

ICPC

Chronic ulcer skin

1.9

11.3

149

817

P99

ICPC

Psychological disorders other

2.3

11.3

372

C10AA05

ATC

atorvastatin; oral

1.3

11.3

935

7651

A23

ICPC

Risk factor NOS

1.6

11.3

240

1510

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.6

11.3

250

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

11.3

627

4817

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

11.2

335

WX320

NOMESCO Finland

Spinalanesthesy

1.4

11.2

564

4255

D07XB02

ATC

triamcinolone; topical

3.4

11.2

120

S22

ICPC

Nail symptom/complaint

1.8

11.2

168

959

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

11.2

448

3242

A06AD11

ATC

lactulose; oral

1.6

11.2

311

2086

J01AA04

ATC

lymecycline; systemic

1.6

11.2

308

2063

S10

ICPC

Boil/carbuncle

1.9

11.2

146

799

A10AC01

ATC

insulin (human); parenteral

1.8

11.1

173

998

L04AA06

ATC

mycophenolic acid; systemic

2.9

11.1

184

UJH02

NOMESCO Finland

Anoscopy

2.2

11.1

460

L14

ICPC

Leg/thigh symptom/complaint

1.7

11.0

196

1175

N03AX12

ATC

[U] gabapentin; oral

1.5

11.0

365

2542

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

4.3

11.0

RK120, ,

NOMESCO Finland

9.2

11.0

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

4.8

11.0

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

10.9

416

H80.9

ICD-10 Finland

Otosclerosis, unspecified

4.0

10.9

D06

ICPC

Abdominal pain localized other

1.7

10.9

215

1326

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

10.9

397

L05

ICPC

Flank/axilla symptom/complaint

1.8

10.9

160

908

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

10.9

214

N01

ICPC

Headache

1.6

10.9

282

1862

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

10.8

692

5434

DGW00

NOMESCO Finland

Dilatation of eustachian tube

10.6

10.8

A01AB04

ATC

amphotericin B; local oral

2.1

10.7

472

R06AE09

ATC

levocetirizine; oral

1.5

10.7

336

2314

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

3.3

10.7

119

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

10.7

214

1326

J01AA07

ATC

tetracycline; systemic

1.5

10.7

339

2341

A10BB12

ATC

glimepiride; oral

1.9

10.6

143

790

R03DA04

ATC

theophylline; systemic, rectal

2.0

10.6

113

577

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

10.6

217

Z94.0

ICD-10 Finland

Kidney transplant status

3.5

10.6

100

R50.9

ICD-10 Finland

Fever, unspecified

1.5

10.5

356

2489

N03AX11

ATC

topiramate; oral

2.5

10.5

259

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

10.5

115

593

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

10.5

324

2225

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

10.4

129

693

R06.5

ICD-10 Finland

Mouth breathing

1.7

10.4

209

1296

P01

ICPC

Feeling anxious/nervous/tense

1.5

10.4

309

2104

S80.0

ICD-10 Finland

Contusion of knee

1.7

10.4

185

1111

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

10.4

255

RK530, ,

NOMESCO Finland

32.6

10.3

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

10.3

151

856

DFE00

NOMESCO Finland

Insertion of cochlear implant

10.6

10.3

A29

ICPC

General symptom/complaint other

1.5

10.2

311

2126

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

10.2

266

1758

U13

ICPC

Bladder symptom/complaint other

2.3

10.2

331

L30.3

ICD-10 Finland

Infective dermatitis

2.1

10.2

422

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

10.2

195

1194

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

10.2

300

2038

-1, ,

NOMESCO Finland

1.3

10.2

776

6251

K30

ICD-10 Finland

Functional dyspepsia

1.6

10.2

263

1735

DFF16

NOMESCO Finland

Speech-in-noise audiometry

13.2

10.1

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.1

10.1

490

R03AC03

ATC

terbutaline; inhalant

1.5

10.1

309

2115

A10BH01

ATC

sitagliptin; oral

1.7

10.1

210

1314

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.4

10.1

289

G51.0

ICD-10 Finland

Bell palsy

2.4

10.1

283

K60.1

ICD-10 Finland

Chronic anal fissure

2.5

10.0

253

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

10.0

115

603

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.5

10.0

L21.0

ICD-10 Finland

Seborrhoea capitis

3.4

10.0

104

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

10.0

217

1373

H61.0

ICD-10 Finland

Perichondritis of external ear

40.2

10.0

H62.2*B36.9

ICD-10 Finland

Otomycosis NOS

40.2

10.0

A11CC03

ATC

alfacalcidol; systemic

2.5

9.9

248

C09CA01

ATC

losartan; oral

1.4

9.9

557

4273

U02

ICPC

Urinary frequency/urgency

1.5

9.9

336

2350

A98

ICPC

Health maint/preventive medicine

1.8

9.9

2489

23950

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

9.9

217

1376

DEA10

NOMESCO Finland

Attico-antrotomy

16.8

9.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

9.8

130

714

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

9.8

256

1691

A10BJ06

ATC

semaglutide; parenteral

1.9

9.8

132

729

M75

ICD-10 Finland

Shoulder lesions

2.0

9.8

109

565

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

26.1

9.8

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

9.8

456

3388

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

9.8

169

1006

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

9.8

244

1596

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.0

9.8

A99

ICPC

Disease/condition unspecnature/site

1.6

9.7

248

1630

XKD00

NOMESCO Finland

Uroflowmetry

1.5

9.7

332

2325

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

9.7

133

739

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

9.7

218

1390

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

9.7

150

866

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

9.6

149

859

J01CF02

ATC

cloxacillin; systemic

2.7

9.6

193

R03AC13

ATC

formoterol; inhalant

1.9

9.6

116

619

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

9.6

114

605

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

9.6

210

1331

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.3

9.6

127

Kela drug reimbursment

Transplant complication

3.0

9.6

138

L04AA01

ATC

[U] ciclosporin

3.3

9.6

107

XF404

NOMESCO Finland

Ambulatory ECG

1.7

9.6

190

1175

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

9.5

199

1246

J45

ICD-10 Finland

Asthma

1.6

9.5

240

1573

R03BA01

ATC

beclometasone; inhalant

1.5

9.5

308

2134

H3603, E113,

ICD-10 Finland

3.8

9.5

K08.80

ICD-10 Finland

Toothache NOS

1.6

9.5

217

1390

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

9.5

142

811

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

9.5

117

629

J04AB02

ATC

rifampicin; systemic

3.2

9.5

118

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.3

9.4

323

A10AB04

ATC

insulin lispro; parenteral

2.2

9.4

349

H62.2*B37.2

ICD-10 Finland

Otitis externa in candidiasis

100.4

9.4

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.3

9.4

311

N05CD07

ATC

temazepam; oral

1.6

9.4

231

1506

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

9.4

127

704

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

9.3

135

763

T89

ICPC

Diabetes insulin dependent

2.0

9.3

100

512

U71

ICPC

Cystitis/urinary infection other

1.7

9.3

154

905

J46

ICD-10 Finland

Status asthmaticus

2.3

9.3

312

N03AG01

ATC

valproic acid; systemic, rectal

1.8

9.3

138

786

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

9.3

226

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

9.3

319

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

9.3

319

N05AH03

ATC

olanzapine; systemic

1.8

9.3

149

869

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

9.3

206

1311

M02AA10

ATC

ketoprofen; topical

1.5

9.2

335

2374

A12AA04

ATC

calcium carbonate; oral

2.9

9.2

152

R01AD05

ATC

budesonide; nasal

1.7

9.2

175

1069

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

9.2

612

4816

L84

ICD-10 Finland

Corns and callosities

2.1

9.2

399

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

9.2

100

515

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

9.2

372

2694

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

9.1

119

651

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

9.1

285

1960

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

2.7

9.1

170

N05AA02

ATC

levomepromazine; systemic

2.0

9.1

455

H01.0

ICD-10 Finland

Blepharitis

1.7

9.1

163

981

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.9

9.1

137

S06

ICPC

Rash localized

1.8

9.1

127

711

A10BH05

ATC

linagliptin; oral

1.9

9.1

109

581

S74

ICPC

Dermatophytosis

2.5

9.0

229

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.4

9.0

A10BK01

ATC

dapagliflozin; oral

1.7

9.0

179

1106

R11

ICD-10 Finland

Nausea and vomiting

1.6

9.0

202

1287

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

9.0

143

831

L04

ICPC

Chest symptom/complaint

1.7

9.0

157

937

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

9.0

125

698

UDM02

NOMESCO Finland

Sinoscopy

2.4

9.0

236

R31

ICD-10 Finland

Unspecified haematuria

1.6

9.0

222

1450

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

8.9

697

5613

M54.8

ICD-10 Finland

Other dorsalgia

1.9

8.9

110

591

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

8.9

138

796

DC1BD

NOMESCO Finland

Temporal bone extensive CT

18.7

8.9

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

8.9

135

774

C10AC01

ATC

colestyramine; oral

2.3

8.9

299

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

8.9

205

1315

H73.8

ICD-10 Finland

Other specified disorders of tympanic membrane

24.1

8.9

R35

ICD-10 Finland

Polyuria

1.7

8.9

156

933

L20

ICPC

Joint symptom/complaint NOS

2.0

8.9

459

L20.0

ICD-10 Finland

Besnier prurigo

1.7

8.9

178

1104

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.0

8.9

432

XG405

NOMESCO Finland

Education on PEF monitoring

2.9

8.9

139

E000003, ,

ATC

2.0

8.9

515

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

8.8

289

2005

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.2

8.8

307

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

8.8

216

1407

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

8.8

153

913

H92.1

ICD-10 Finland

Otorrhoea

8.6

8.8

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.9

8.8

112

609

EB1AA, ,

SPAT

1.7

8.8

155

929

RK290, ,

NOMESCO Finland

9.5

8.8

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

8.8

216

1409

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

8.7

407

C10AA01

ATC

simvastatin; oral

1.3

8.7

843

6989

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

8.7

111

603

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.5

8.7

227

S01AA01

ATC

chloramphenicol; ophthalmic

1.9

8.7

109

589

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

8.7

172

1062

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

8.7

252

1704

A10AB05

ATC

insulin aspart; parenteral

1.7

8.7

173

1070

B35.3

ICD-10 Finland

Tinea pedis

1.9

8.7

110

597

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

8.6

672

5406

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

8.6

170

1049

R81

ICPC

Pneumonia

2.0

8.6

450

P03

ICPC

Feeling depressed

1.5

8.6

235

1568

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.0

8.6

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

8.6

143

843

C05AA08

ATC

fluocortolone; rectal, topical

1.5

8.6

283

1967

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

8.6

108

585

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

8.6

465

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

8.2

8.6

Z50.1

ICD-10 Finland

Other physical therapy

1.8

8.5

116

644

L04AX01

ATC

azathioprine; systemic

2.0

8.5

501

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

8.5

489

3757

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

8.5

148

884

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

8.5

229

1525

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.2

8.5

100

XG466

NOMESCO Finland

Sleep oxymetry

2.2

8.5

319

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.1

8.5

392

M54

ICD-10 Finland

Dorsalgia

1.5

8.4

285

1990

Z2445

NOMESCO Finland

Psychologist

2.0

8.4

489

N06AX03

ATC

mianserin; oral

1.9

8.4

105

567

H93.1

ICD-10 Finland

Tinnitus

1.7

8.4

154

932

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.4

8.4

231

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

8.4

235

1578

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

8.4

146

872

RK420, ,

NOMESCO Finland

12.8

8.4

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.1

8.4

347

S01

ICPC

Pain/tenderness of skin

1.8

8.4

111

612

R07.0

ICD-10 Finland

Pain in throat

1.7

8.3

168

1043

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

8.3

463

T14.1

ICD-10 Finland

Open wound of unspecified body region

4.0

8.3

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

8.3

489

3769

P29

ICPC

Psychological sympt/compl other

1.6

8.3

178

1122

J33.8

ICD-10 Finland

Other polyp of sinus

2.4

8.3

220

A10AE05

ATC

insulin detemir; parenteral

1.8

8.3

119

672

A03FA02

ATC

cisapride; oral, rectal

1.7

8.3

149

898

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

8.3

117

658

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

8.3

129

747

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

8.2

128

740

S20

ICPC

Corn/callosity

2.4

8.2

215

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

8.2

696

5659

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.2

488

3766

C09CA06

ATC

candesartan; oral

1.3

8.2

539

4224

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

8.2

110

608

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.3

8.2

265

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.0

8.2

118

N03AE01

ATC

clonazepam; systemic

1.8

8.2

120

682

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

8.2

113

631

T92

ICPC

Gout

2.5

8.2

204

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

8.1

137

811

SPAT1039

SPAT

Otomicroscopy

2.8

8.1

146

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

8.1

405

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.6

8.1

WX110, ,

SPAT

1.7

8.1

136

804

ACC51

NOMESCO Finland

Release of median nerve

1.6

8.1

170

1067

N06AA09

ATC

amitriptyline; systemic

1.6

8.0

192

1244

R4190

NOMESCO Finland

Nutritional therapy

1.9

8.0

491

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.1

8.0

104

R55

ICD-10 Finland

Syncope and collapse

1.5

8.0

231

1563

D02

ICPC

Abdominal pain epigastric

1.7

8.0

143

862

P06

ICPC

Sleep disturbance

1.5

7.9

298

2124

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

7.9

321

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.4

7.9

XCK00

NOMESCO Finland

Perimetry

1.8

7.9

122

704

K04.0

ICD-10 Finland

Pulpitis

1.6

7.9

207

1369

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

7.9

375

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

7.9

529

L29

ICPC

Musculoskeletal sympt/complt other

1.6

7.9

200

1314

H10

ICD-10 Finland

Conjunctivitis

1.6

7.9

171

1083

TDA90, ,

SPAT

1.7

7.8

151

927

J01MA14

ATC

moxifloxacin; systemic

1.6

7.8

194

1267

R51.81

ICD-10 Finland

Facial pain NOS

2.2

7.8

290

J01MA06

ATC

norfloxacin; oral

1.5

7.8

263

1835

M89.0

ICD-10 Finland

Algoneurodystrophy

3.5

7.8

M35.7

ICD-10 Finland

Hypermobility syndrome

2.8

7.8

138

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

7.8

452

3474

-51

ICPC

I&d/flush/aspiration

3.4

7.8

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.3

7.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

7.8

247

1703

K29

ICPC

Cardiovascular sympt/complt other

1.9

7.8

496

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

3.0

7.8

111

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

7.7

289

2058

SPAT1254

SPAT

Administration of medicine

1.4

7.7

312

2255

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

7.7

567

4515

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.4

7.7

210

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.6

7.7

174

N05AX12

ATC

aripiprazole; systemic

1.9

7.6

506

RK220, ,

NOMESCO Finland

4.5

7.6

Z00.8

ICD-10 Finland

Other general examinations

1.6

7.6

175

1124

D02AE01

ATC

carbamide; topical

1.7

7.6

134

804

K07

ICPC

Swollen ankles/oedema

1.8

7.6

102

565

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

7.6

266

1872

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

25.1

7.6

R13

ICD-10 Finland

Dysphagia

1.6

7.6

156

975

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

7.6

551

4382

A10BK03

ATC

empagliflozin; oral

1.5

7.5

227

1548

OSTO, ,

NOMESCO Finland

3.2

7.5

G04BD12

ATC

mirabegron; oral

1.5

7.5

247

1715

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

7.5

100

552

137

Kela drug reimbursment

Uraemia requiring dialysis

3.4

7.5

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.3

7.5

225

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

7.5

404

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

7.5

370

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.9

7.4

A06AC51

ATC

ispaghula, combinations; oral

1.8

7.4

540

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

7.4

145

894

DCA00

NOMESCO Finland

Biopsy of tympanic membrane or middle ear

80.3

7.4

H76

ICPC

Foreign body in ear

3.6

7.4

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

7.4

111

636

K29.1

ICD-10 Finland

Other acute gastritis

2.9

7.4

120

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

7.4

106

600

L08

ICPC

Shoulder symptom/complaint

1.3

7.4

517

4088

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.4

7.4

202

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

7.3

143

881

K85

ICPC

Elevated blood pressure

1.4

7.3

345

2561

N06AX26

ATC

vortioxetine; oral

1.6

7.3

168

1078

M02AA07

ATC

piroxicam; topical

1.3

7.3

737

6117

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

7.3

126

751

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

7.3

100

557

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

7.3

223

1525

M01AX17

ATC

nimesulide; oral

1.3

7.3

486

3813

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

7.3

155

977

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.6

7.3

155

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.6

7.3

155

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.3

519

4112

K04.09

ICD-10 Finland

Pulpit UNS

1.8

7.3

107

610

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

15.8

7.2

R78

ICPC

Acute bronchitis/bronchiolitis

2.4

7.2

210

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

7.2

459

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.5

7.2

248

1739

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.8

7.2

105

597

N06AB06

ATC

sertraline; oral

1.5

7.2

250

1756

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

7.2

341

L86

ICPC

Back syndrome with radiating pain

1.7

7.2

136

832

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

7.2

488

P80

ICPC

Personality disorder

4.5

7.2

X57

ICD-10 Finland

Unspecified privation

2.3

7.2

236

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

7.2

185

1221

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

2.7

7.2

139

M54.2

ICD-10 Finland

Cervicalgia

1.6

7.2

184

1213

H83.1

ICD-10 Finland

Labyrinthine fistula

30.1

7.1

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

30.1

7.1

4224

FHL

Endonasal anthrostomy

3.1

7.1

LASKU, ,

NOMESCO Finland

3.4

7.1

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

7.1

548

D01BA02

ATC

terbinafine; oral

1.3

7.1

551

4417

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.0

7.1

391

D16

ICPC

Rectal bleeding

2.2

7.1

263

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

7.1

177

1160

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

7.1

206

XA420

NOMESCO Finland

Extensive sleep examination

3.0

7.0

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

7.0

232

1614

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

7.0

245

1723

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

7.0

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

7.0

112

655

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

7.0

277

1996

S15

ICPC

Foreign body in skin

1.6

6.9

144

902

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

6.9

158

1013

C10AA04

ATC

fluvastatin; oral

1.6

6.9

164

1061

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.8

6.9

516

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

6.9

231

1610

Z97.8

ICD-10 Finland

Presence of other specified devices

5.8

6.9

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

6.9

1151

10121

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.9

299

2188

DCW99

NOMESCO Finland

Other operation on eardrum and middle ear

13.8

6.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

6.9

156

999

XG460

NOMESCO Finland

Short time oxymetry

2.6

6.9

142

C01CA24

ATC

epinephrine; parenteral

1.6

6.9

142

889

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.1

6.9

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.4

6.9

178

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.8

753

6310

S09

ICPC

Infected finger/toe

2.0

6.8

389

A02BA04

ATC

nizatidine; systemic

1.6

6.8

144

906

L73.8

ICD-10 Finland

Other specified follicular disorders

3.0

6.8

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

6.8

168

1098

DFX00

NOMESCO Finland

Connecting cochlear implant

9.3

6.8

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.8

382

2920

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

6.8

125

760

SPF30

NOMESCO Finland

Relining of denture

2.5

6.8

155

H74.4

ICD-10 Finland

Polyp of middle ear

40.2

6.8

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.9

6.8

398

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

3.6

6.7

A91

ICPC

Abnormal result investigation NOS

1.7

6.7

122

738

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.8

6.7

115

H91.1

ICD-10 Finland

Presbycusis

1.7

6.7

123

746

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

6.7

565

DFF59

NOMESCO Finland

Other assessment of balance

3.0

6.7

B05DA

ATC

Isotonic solutions

3.4

6.7

D12

ICPC

Constipation

1.9

6.7

442

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

6.7

107

626

H74

ICPC

Chronic otitis media

22.6

6.7

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.2

6.7

250

ZY010

NOMESCO Finland

Hospital outpatient

1.7

6.7

117

702

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

6.7

124

756

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.6

6.6

150

960

-62

ICPC

Administrative procedure

2.0

6.6

324

SFA00

NOMESCO Finland

Small restoration

1.4

6.6

311

2307

D10

ICPC

Vomiting

1.6

6.6

132

820

T82

ICPC

Obesity

1.8

6.6

517

A10BJ02

ATC

liraglutide; parenteral

2.0

6.6

339

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

6.6

256

1838

A10BJ05

ATC

dulaglutide; parenteral

2.3

6.6

213

K04.08

ICD-10 Finland

Other specified pulpit

1.5

6.6

178

1188

UDQ02

NOMESCO Finland

Direct laryngoscopy

3.2

6.6

L18

ICPC

Muscle pain

1.8

6.6

547

N05BB01

ATC

hydroxyzine; systemic

1.7

6.6

128

790

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

6.6

163

1067

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

6.6

152

979

M01AB51

ATC

indometacin, combinations; oral, rectal

2.2

6.6

226

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.2

6.5

N06AA10

ATC

nortriptyline; systemic

2.3

6.5

220

M01AB55

ATC

diclofenac, combinations; oral

1.6

6.5

128

792

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.1

6.5

293

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

6.5

126

777

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

6.5

218

1522

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

6.5

263

1903

N02AA05

ATC

oxycodone; systemic

1.4

6.5

372

2852

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.1

6.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

6.5

168

1111

4141

FHL

Myringoplasty (also for reasons other than inflammation)

6.2

6.5

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

6.5

147

943

H57.1

ICD-10 Finland

Ocular pain

1.8

6.4

513

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.4

482

3840

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

6.4

215

S06.0

ICD-10 Finland

Concussion

1.5

6.4

230

1625

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

6.4

136

857

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.1

6.4

261

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

14.3

6.4

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

6.4

268

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

6.4

148

954

A10BG03

ATC

pioglitazone; oral

2.1

6.4

255

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

6.4

142

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.6

6.4

142

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

6.4

201

1386

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

6.3

124

766

N05BA12

ATC

alprazolam; oral

1.5

6.3

203

1404

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.5

6.3

206

1429

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

3.6

6.3

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.2

6.3

F03

ICPC

Eye discharge

1.6

6.3

151

981

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

3.5

6.3

L40.8

ICD-10 Finland

Other psoriasis

3.5

6.3

WW200

NOMESCO Finland

Immunization

2.1

6.3

290

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

6.3

290

R06AX13

ATC

loratadine; oral

1.4

6.3

320

2407

R00.2

ICD-10 Finland

Palpitations

1.5

6.3

172

1152

R52.2

ICD-10 Finland

Other chronic pain

1.8

6.3

474

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

6.2

445

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.3

6.2

205

DHB50

NOMESCO Finland

Turbinoplasty

2.0

6.2

318

K05.1

ICD-10 Finland

Chronic gingivitis

1.6

6.2

150

975

A10AB01

ATC

insulin (human); parenteral

1.9

6.2

374

D02AX

ATC

Other emollients and protectives

2.0

6.2

339

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

6.2

141

904

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.0

6.2

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

7.0

6.2

G04AC01, ,

ATC

2.1

6.2

271

L71.9

ICD-10 Finland

Rosacea, unspecified

2.0

6.2

305

W55

ICD-10 Finland

Bitten or struck by other mammals

1.9

6.2

396

C05AA01

ATC

hydrocortisone; rectal, topical

1.7

6.2

100

587

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

6.2

389

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

6.2

120

740

N30

ICD-10 Finland

Cystitis

1.5

6.2

176

1188

C03DA01

ATC

spironolactone; oral

1.4

6.2

243

1748

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.0

6.2

292

SPAT1216

SPAT

Assessment of functional ability

1.4

6.2

293

2178

N05CF02

ATC

zolpidem; oral

1.3

6.2

364

2801

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

6.2

181

A10AA01, ,

ATC

2.1

6.2

272

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.9

6.1

390

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

6.1

310

2328

R4180, ,

SPAT

2.6

6.1

127

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.9

6.1

369

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

6.1

116

711

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

7.7

6.1

V03AE01

ATC

polystyrene sulfonate; oral

2.7

6.1

110

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.3

6.1

188

Y94.0

ICD-10 Finland

Accident at home

2.3

6.1

188

H26.9

ICD-10 Finland

Cataract, unspecified

2.5

6.1

151

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.5

6.1

205

1431

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

6.1

522

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

6.1

391

M04AA01

ATC

allopurinol; systemic

1.4

6.1

250

1812

H93.9

ICD-10 Finland

Disorder of ear, unspecified

3.8

6.1

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.8

6.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

6.1

363

SAA04

NOMESCO Finland

Special examination of mouth

1.7

6.1

115

705

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

6.1

176

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

6.1

240

1728

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

6.1

106

636

M79.7

ICD-10 Finland

Fibromyalgia

1.9

6.1

406

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

6.1

133

846

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

6.1

105

EBA00, ,

SPAT

2.0

6.0

308

L99

ICPC

Musculoskeletal disease other

2.2

6.0

234

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.1

6.0

274

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

6.0

176

1194

D01AC02

ATC

miconazole; topical

1.6

6.0

153

1007

G04CA01

ATC

alfuzosin; oral

1.4

6.0

251

1824

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.5

6.0

194

1343

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

6.0

288

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.0

6.0

288

E000007, ,

ATC

1.7

6.0

112

684

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

943

2654

5.00

318.01

2.6

1.7

—

(3000494) Fungus identified in Specimen by Culture

729

2782

3.25

144.34

2.1

1.4

—

(3042936) Bacteria identified in Isolate by Culture

652

3328

2.28

65.64

2.2

2.1

—

(42870588) Differential panel, method unspecified - Blood

1181

7799

1.94

57.74

7.4

6.3

—

(3018010) Neutrophils/Leukocytes in Blood

1521

11019

1.91

55.13

7.7

6.4

57.06

57.07

0.01

1426

10579

(3022096) Basophils/Leukocytes in Blood

1498

10910

1.87

52.17

8.0

6.6

0.69

0.68

0.29

1396

10264

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1395

9956

1.86

51.59

2.5

2.1

96.19

95.84

pmol/l

0.09

739

5415

(3006504) Eosinophils/Leukocytes in Blood

1495

10911

1.87

51.40

7.9

6.5

2.86

2.83

0.27

1392

10278

(3019069) Monocytes/Leukocytes in Blood

1496

10930

1.86

51.15

8.0

6.6

8.65

8.78

1.23

1390

10297

(3002030) Lymphocytes/Leukocytes in Blood

1513

11224

1.83

47.86

7.9

6.5

28.26

28.03

0.35

1430

10690

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

499

2564

2.17

47.76

5.3

4.8

31.76

32.33

0.54

351

1761

(3013115) Eosinophils [#/volume] in Blood

1608

12307

1.80

44.20

7.8

6.5

0.20

0.19

e9/l

1.75

1388

10810

(3006315) Basophils [#/volume] in Blood

1560

11926

1.76

42.07

7.6

6.3

0.04

e9/l

1.41

1315

10313

(3001604) Monocytes [#/volume] in Blood

1556

11896

1.76

41.86

7.7

6.3

0.59

0.58

e9/l

1.60

1319

10284

(3019198) Lymphocytes [#/volume] in Blood

1584

12182

1.76

41.64

7.7

6.4

2.00

1.95

e9/l

0.38

1388

10804

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

628

3673

1.93

41.42

3.3

3.1

3.34

2.39

e6/l

1.14

327

1779

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1366

10097

1.74

41.12

7.6

6.8

1.22

1.21

mmol/l

3.07

1276

9366

(3033658) Prothrombin time (PT) actual/Normal

891

5870

1.79

39.90

4.5

4.2

90.87

90.10

0.39

872

5743

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2059

17358

1.88

37.12

9.5

8.2

78.16

78.82

u/l

0.26

1976

16536

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2009

16834

1.84

36.58

5.3

4.3

12.25

11.63

mm/h

1.19

1884

15825

(3013826) Glucose [Moles/volume] in Serum or Plasma

1684

13480

1.70

35.32

5.9

5.2

6.87

6.67

mmol/l

3.04

1600

12757

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1539

12035

1.68

35.22

6.3

6.6

10.65

11.48

umol/l

2.89

1471

11488

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

855

5737

1.73

34.89

2.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1664

13327

1.68

34.33

10.3

9.6

4.21

4.11

e9/l

0.51

1406

11632

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

292

1371

2.27

34.21

1.8

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1458

11302

1.66

33.97

8.7

7.4

1.22

1.21

mmol/l

1.95

1333

9796

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

642

3997

1.80

33.81

3.2

2.9

0.89

1.08

e6/l

0.61

344

2109

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

414

2249

2.00

33.14

2.7

2.4

29.10

61.83

u/l

0.88

345

1892

(3019225) pH of Specimen

379

2040

2.00

31.00

5.4

4.2

7.37

7.35

0.84

280

1499

(3044640) Blood type and Crossmatch panel - Blood

1035

7514

1.63

30.13

2.7

2.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1790

14857

1.65

29.77

5.5

4.5

2648.78

1473.42

e6/l

—

211

(40768804) Tissue Pathology biopsy report

1208

9142

1.60

29.36

2.4

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

595

3771

1.75

28.86

2.1

1.9

—

(3023368) Bacteria identified in Blood by Culture

883

6219

1.63

28.73

4.6

4.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2431

22204

2.37

28.42

21.2

15.6

22.70

23.69

mg/l

0.84

2138

18263

(3018095) Leukocytes [#/volume] in Urine

1143

8583

1.59

28.40

4.7

3.9

98.99

98.60

e6/l

0.01

779

5982

(3024561) Albumin [Mass/volume] in Serum or Plasma

1312

10175

1.58

28.36

5.9

5.1

35.87

35.82

g/l

0.14

1226

9556

(3021960) Folate [Moles/volume] in Serum or Plasma

890

6396

1.59

26.06

1.8

1.7

19.91

20.08

nmol/l

0.14

760

5496

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

189

829

2.38

25.77

5.0

4.2

24.67

24.86

mmol/l

0.39

175

777

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2344

21270

1.99

25.31

19.8

15.0

83.63

82.99

ml/min/173m2

0.74

2179

19672

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2307

20839

1.92

25.02

6.5

5.3

1.92

1.89

mu/l

0.20

2134

19462

(3019550) Sodium [Moles/volume] in Serum or Plasma

2437

22515

2.23

23.74

23.9

18.1

139.58

139.68

mmol/l

1.34

2400

22086

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

944

7001

1.55

23.48

2.2

161.78

223.42

u/l

2.11

904

6656

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1828

15624

1.57

23.37

4.0

3.3

53.48

46.96

u/l

1.61

1734

14778

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

646

4396

1.62

23.24

4.3

3.9

345.52

671.41

ng/l

0.61

476

3294

(3032080) INR in Blood by Coagulation assay

1293

10279

1.51

23.09

15.7

14.5

1.24

inr

0.03

1043

8583

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

733

5165

1.58

22.71

1.8

1.07

1.17

mg/l

0.37

559

3980

(3023103) Potassium [Moles/volume] in Serum or Plasma

2436

22568

2.18

22.46

24.3

18.3

3.96

3.97

mmol/l

0.38

2394

22102

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

878

6475

1.54

22.08

3.1

3.2

1331.59

1243.60

ng/l

0.25

727

5573

(3007164) IgA [Mass/volume] in Serum or Plasma

700

4909

1.58

22.02

1.6

1.5

2.43

2.42

g/l

0.04

385

3114

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

433

2701

1.72

21.59

2.5

2.8

9.68

7.87

umol/l

0.59

379

2387

(3022313) Gas panel - Capillary blood

212

1058

2.09

21.05

5.2

4.0

—

(40768797) Stomach Pathology biopsy report

492

3198

1.66

20.98

1.3

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

835

6164

1.52

20.58

2.6

2.3

2.82

2.74

mg/l

0.30

709

5345

(40758558) Short blood count panel - Blood

933

7060

1.50

20.38

6.9

6.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

536

3595

1.62

20.08

1.8

1.7

977.68

1153.80

nmol/l

5.06

384

2791

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1707

14582

1.49

20.04

3.5

3.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1034

8025

1.48

19.74

3.4

3.2

32.95

32.82

u/l

0.02

971

7597

(3026493) Urate [Moles/volume] in Serum or Plasma

809

5977

1.51

19.68

3.0

2.7

344.81

340.33

umol/l

0.59

706

5314

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1286

10419

1.46

19.64

2.9

2.5

75.75

76.65

nmol/l

0.54

1150

9525

(3009508) Creatinine [Moles/volume] in Urine

1027

7967

1.48

19.62

4.1

3.5

7.47

7.70

mmol/l

0.86

856

6846

(3002582) Erythrocytes [#/volume] in Urine

971

7452

1.48

19.57

3.9

3.4

46.79

92.94

e6/l

1.60

742

5672

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1380

11359

1.46

19.23

3.6

3.2

107.16

117.65

ug/l

1.33

1285

10684

(36660697) Celiac disease serology panel - Serum

323

1918

1.78

19.00

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

270

1519

1.87

18.95

5.1

3.9

5.15

kpa

0.03

258

1464

(3014111) Lactate [Moles/volume] in Serum or Plasma

347

2116

1.74

18.59

8.4

8.5

1.29

1.34

mmol/l

0.55

340

2073

(3037522) Nuclear Ab [Titer] in Serum

499

3346

1.61

18.56

1.4

480.38

488.20

titre

0.04

105

693

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

434

2816

1.65

18.43

1.9

1.8

—

(3037121) Protein [Mass/volume] in Urine

166

796

2.16

18.27

4.2

3.4

255.92

319.61

mg/l

0.60

343

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

174

850

2.12

18.26

2.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

161

764

2.18

18.19

1.9

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1993

17725

1.52

18.03

4.9

4.4

14.59

14.72

pmol/l

1.61

1819

16410

(3030467) Casts [#/volume] in Urine by Automated count

846

6428

1.47

17.46

3.9

3.2

0.31

0.41

e6/l

1.40

605

4695

(3014051) Protein [Presence] in Urine by Test strip

867

6622

1.46

17.40

3.2

2.9

0.00

0.02

—

125

(3009343) pH of Capillary blood

259

1478

1.84

17.33

5.1

3.9

7.42

0.10

219

1246

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

235

1305

1.88

17.14

5.0

3.8

1.19

1.80

mmol/l

1.92

184

971

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2265

20812

1.66

17.09

7.9

6.1

40.52

39.01

mmol/mol

10.07

2104

19616

(3022948) Iron [Moles/volume] in Serum or Plasma

560

3948

1.53

16.52

3.0

2.6

13.08

13.32

umol/l

0.34

524

3676

(3004789) Transferrin [Mass/volume] in Serum or Plasma

527

3677

1.54

16.28

2.9

2.6

2.34

2.32

g/l

0.26

491

3397

(3020682) Albumin/Creatinine [Ratio] in Urine

948

7471

1.42

15.66

5.0

4.2

8.99

8.49

mg/mmol

0.13

618

4750

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

489

3386

1.55

15.56

3.0

2.6

22.38

23.14

0.68

451

3153

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2472

23402

2.05

15.55

14.9

11.9

27.43

26.26

u/l

2.09

2410

22800

(3012516) Albumin [Mass/volume] in Urine

931

7345

1.42

15.16

4.2

3.5

46.44

48.42

mg/l

0.12

619

4788

(3000991) Gas panel - Venous blood

327

2069

1.66

15.14

10.4

9.7

—

(3052851) Hemolysis interference index of Serum or Plasma

131

618

2.18

15.04

3.1

3.4

3.54

2.04

index

0.45

328

(1761868) Lipid panel - Serum or Plasma

698

9022

0.69

15.01

3.0

3.1

—

(4146454) Self-monitoring of blood glucose

219

3.02

14.99

3.2

2.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2482

23579

2.06

14.69

26.4

19.9

78.85

76.62

umol/l

1.94

2457

23330

(3003327) Ova and parasites identified in Stool by Light microscopy

159

817

2.01

14.57

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

246

1466

1.75

14.18

1.2

1.3

31.44

50.91

au/ml

—

104

(3048689) Calprotectin [Mass/mass] in Stool

450

3123

1.53

14.05

2.9

2.5

137.81

125.59

ug/g

0.30

345

2533

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

262

1600

1.71

13.83

2.4

12.00

21.00

au/ml

2.31

173

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

598

4412

1.46

13.81

1.4

1.3

27.13

30.80

iu/ml

0.29

165

1345

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

917

7308

1.39

13.74

3.0

2.7

53.44

59.38

u/l

3.63

853

6797

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

735

5643

1.42

13.66

1.4

1.3

1.36

1.69

u/ml

0.58

134

1557

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

153

797

1.98

13.50

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

235

1407

1.74

13.31

10.7

10.8

24.28

24.23

mmol/l

0.10

230

1382

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

164

880

1.92

13.27

1.6

1.7

18.50

14.16

u/ml

0.57

215

(3045424) Erythrocytes [Presence] in Urine

192

1091

1.82

12.99

2.6

2.2

0.00

0.73

estimate

0.50

347

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1285

10881

1.36

12.91

3.0

2.9

—

estimate

—

(3002619) Bacteria identified in Specimen by Culture

5.25

12.48

1.6

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

130

658

2.03

12.45

1.5

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1033

8499

1.36

12.33

3.9

3.7

42.53

67.14

ng/l

0.87

686

5767

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

270

1717

1.64

12.18

1.5

1.4

—

(3022145) Colonoscopy Study observation

381

2628

1.53

12.12

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

259

2.63

12.04

2.3

18.10

20.63

mg/l

0.27

108

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2275

21285

1.53

11.86

6.1

5.0

6.08

5.90

mmol/l

7.37

2114

19717

(3000963) Hemoglobin [Mass/volume] in Blood

2522

24262

2.15

11.80

31.6

23.8

134.80

135.39

g/l

1.23

2501

24033

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2521

24250

2.14

11.78

31.3

23.6

90.93

90.96

0.15

2499

24021

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

552

4119

1.43

11.77

1.4

1.3

16.23

10.50

u/ml

0.26

175

1626

(3045414) Leukocytes [Presence] in Urine

323

2162

1.56

11.75

2.5

2.1

0.00

0.02

estimate

1.06

465

(3035941) MCH [Entitic mass]

2521

24252

2.13

11.75

31.3

23.6

30.24

30.30

1.04

2499

24022

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2521

24253

2.13

11.73

32.3

24.2

40.39

40.60

0.50

2499

24010

(3026361) Erythrocytes [#/volume] in Blood

2521

24253

2.13

11.73

31.4

23.6

4.50

e12/l

0.01

2475

23729

(3010813) Leukocytes [#/volume] in Blood

2521

24257

2.13

11.66

31.5

23.7

6.98

6.76

e9/l

3.73

2475

23729

(3007461) Platelets [#/volume] in Blood

2520

24245

2.12

11.64

31.5

23.7

253.17

252.17

e9/l

0.33

2481

23797

(3018418) pH of Serum or Plasma

844

6776

1.36

11.62

4.7

4.2

7.39

7.40

0.81

587

4871

(3017143) Hepatitis C virus Ab [Presence] in Serum

407

2872

1.49

11.58

1.9

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

525

3894

1.44

11.54

3.4

3.5

0.81

0.82

mmol/l

2.35

484

3699

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

384

2680

1.51

11.52

2.0

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

332

2252

1.54

11.37

2.4

2.3

0.21

g/l

0.26

308

2103

(3015377) Calcium [Moles/volume] in Serum or Plasma

967

7947

1.34

11.37

3.6

3.4

2.35

mmol/l

0.16

850

7263

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

226

2.69

11.36

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

860

1.85

11.34

2.6

2.4

2.74

2.91

g/l

1.78

140

794

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

259

1662

1.62

11.25

1.8

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

258

2.56

11.10

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

258

2.56

11.10

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

259

2.55

11.01

1.6

1.4

—

(3026008) Bacteria identified in Urine by Culture

838

6767

1.35

10.97

3.4

3.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

444

2.16

10.83

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

444

2.16

10.83

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

134

723

1.90

10.70

1.3

1.2

4.00

52.57

u/ml

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

269

2.49

10.68

1.6

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

428

3097

1.46

10.67

7.9

6.1

1.04

mmol/l

0.19

390

2893

(3024522) Salmonella sp identified in Specimen by Organism specific culture

271

2.47

10.52

1.6

1.4

—

(40761536) Microorganisms panel - Urine sediment

1894

0.50

10.38

4.8

3.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

273

2.45

10.36

1.6

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

250

1623

1.60

10.35

1.5

1.3

463.00

200.56

u/ml

0.70

234

1513

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

214

2.65

10.34

1.3

1.2

49.78

59.80

u/l

0.95

192

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

917

1.78

10.27

2.6

2.3

4.28

4.22

g/l

0.47

144

850

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

917

1.78

10.27

2.6

2.3

7.43

7.34

g/l

0.32

144

850

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

108

551

2.00

10.16

1.2

1.46

4.22

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

126

679

1.90

10.11

1.3

1.2

5.04

2.41

u/ml

0.59

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

126

682

1.89

9.98

1.3

17.75

11.28

u/ml

0.28

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2344

22235

1.53

9.71

6.6

5.6

2.66

2.71

mmol/l

1.78

2180

20890

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

223

1431

1.61

9.68

4.5

4.2

24.14

24.15

mmol/l

0.03

218

1416

(3004616) Nuclear Ab [Presence] in Serum

282

2.38

9.68

1.5

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

140

793

1.81

9.61

2.4

0.12

1.09

g/l

8.02

125

692

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

256

1703

1.56

9.53

5.1

4.1

97.65

89.15

ng/l

0.58

222

1500

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

156

917

1.75

9.45

2.6

2.3

3.55

3.73

g/l

1.11

142

850

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

399

2927

1.43

9.16

1.8

1.51

1.47

0.57

352

2578

(3005719) IgG [Mass/volume] in Serum or Plasma

275

1875

1.52

9.15

2.4

2.8

10.27

10.64

g/l

0.89

254

1738

(3021879) Hepatitis B virus core Ab [Presence] in Serum

278

1900

1.52

9.15

1.7

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

193

2.62

9.09

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

194

2.61

9.00

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

189

2.62

8.93

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

234

2.42

8.66

1.4

1.3

1.49

1.47

nmol/l

0.03

214

(40759836) Histone Ab [Presence] in Serum by Immunoblot

195

2.54

8.40

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2311

21965

1.45

8.37

5.8

5.0

4.54

4.63

mmol/l

3.63

2155

20729

(3020779) Urea [Moles/volume] in Serum or Plasma

298

2105

1.47

8.33

9.6

7.5

10.57

9.62

mmol/l

1.26

276

2028

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

202

2.50

8.31

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

100

1778

0.55

8.26

5.6

3.7

1.23

mmol/l

0.11

1530

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

363

2672

1.42

8.13

4.5

231.20

244.95

u/l

1.58

348

2539

(3000570) Elastase.pancreatic [Mass/mass] in Stool

121

691

1.79

8.13

1.5

1.4

281.85

284.16

ug/g

0.04

407

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

107

591

1.85

8.02

1.3

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

180

1156

1.60

7.81

1.7

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

159

991

1.64

7.79

2.0

1.8

6.88

7.32

iu/ml

0.09

229

(1002224) Polysomnography panel

179

1149

1.60

7.79

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2296

21847

1.42

7.77

5.8

4.9

1.40

1.46

mmol/l

10.60

2133

20482

(3021589) Normoblasts [#/volume] in Blood

1186

10375

1.26

7.74

11.2

0.00

e9/l

1.34

908

8503

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

369

2.03

7.51

1.4

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

281

2006

1.45

7.43

2.4

2.8

70.84

70.29

e9/l

0.09

196

1468

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

565

4521

1.32

7.40

1.7

1.6

—

(3015736) pH of Urine

1120

9767

1.26

7.40

3.6

3.4

6.17

6.22

0.83

547

5575

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2201

20832

1.36

7.38

4.8

4.2

1.39

1.28

mmol/l

6.78

2019

19374

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

131

2.77

7.38

1.5

1.6

7.74

5.07

u/l

0.40

109

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

184

2.47

7.34

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

583

4691

1.31

7.33

2.2

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1098

9561

1.26

7.32

2.1

1.9

1.44

1.36

mmol/l

2.24

961

8154

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.24

7.24

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.24

7.24

1.6

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

180

2.47

7.17

1.1

—

(40768443) Skin Pathology biopsy report

155

982

1.61

7.13

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

357

2679

1.39

7.11

2.5

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

797

1.68

7.07

2.5

2.3

9.57

10.31

g/l

1.50

115

725

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

115

679

1.73

6.93

2.7

2.2

0.01

0.02

g/l

0.63

108

615

(3033099) Centromere Ab [Titer] in Serum

5.46

6.91

1.1

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

349

2624

1.38

6.87

2.6

2.9

1.83

1.80

0.29

303

2355

(3000850) Epithelial cells [#/volume] in Urine

628

5144

1.29

6.85

2.9

2.7

5.40

5.81

e6/l

0.34

554

4665

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

114

2.83

6.84

1.6

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

115

2.80

6.74

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

493

3928

1.31

6.59

1.8

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

118

712

1.69

6.59

2.0

1.7

0.22

0.23

g/l

0.53

112

683

(3017732) Neutrophils [#/volume] in Blood

386

2969

1.35

6.57

3.5

3.3

4.25

4.77

e9/l

1.18

305

2614

(3020630) Protein [Mass/volume] in Serum or Plasma

260

1876

1.43

6.49

2.7

2.8

66.68

66.55

g/l

0.10

234

1747

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

556

4514

1.29

6.45

3.4

2.9

2.44

mmol/l

0.34

491

4047

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

105

618

1.73

6.42

2.8

2.3

0.00

g/l

-0.00

583

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

120

733

1.67

6.41

2.0

1.7

1.18

1.19

g/l

0.12

115

702

(4024509) Urine culture

159

1042

1.56

6.37

2.2

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

393

1.91

6.33

1.4

1.6

0.71

0.80

g/l

0.32

316

(3028707) Methadone [Presence] in Urine by Screen method

436

1.86

6.32

1.7

2.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

160

1052

1.55

6.32

2.2

1.9

1.61

1.51

g/l

0.69

144

918

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

554

1.76

6.30

1.2

8.21

53.09

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

379

2929

1.34

6.24

2.6

2.2

—

(3020491) Glucose [Moles/volume] in Blood

151

2.47

6.11

1.8

2.0

6.89

6.77

mmol/l

0.09

105

(3000475) Leukocytes [#/volume] in Synovial fluid

582

1.73

6.10

1.6

10598.46

13287.14

e6/l

0.24

412

(3024928) Oxygen saturation in Venous blood

104

620

1.71

6.09

3.6

3.2

61.30

61.46

0.02

600

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

3.00

5.95

1.0

2.81

9.57

u/ml

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.00

5.95

1.5

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.00

5.95

1.5

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.00

5.95

1.6

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

223

2.17

5.92

3.1

4.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

291

2.02

5.86

1.4

—

(40768446) Kidney Pathology biopsy report

2.96

5.84

1.8

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

226

1627

1.43

5.73

1.2

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

148

986

1.53

5.54

1.9

1.5

9.78

22.92

iu/ml

—

(3028026) IgM [Mass/volume] in Serum or Plasma

208

1486

1.43

5.50

1.6

1.9

1.24

1.36

g/l

0.41

188

1380

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

163

1111

1.50

5.49

2.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

107

662

1.64

5.48

2.8

2.3

0.00

g/l

-0.00

100

584

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

487

1.75

5.47

2.0

1.6

—

(3026782) Osmolality of Urine

533

4389

1.27

5.44

3.2

2.9

532.90

532.65

mosm/kgh2o

0.01

454

3832

(3009466) Valproate [Moles/volume] in Serum or Plasma

342

1.89

5.42

5.9

6.1

347.63

362.74

umol/l

0.41

308

(3011288) Drugs identified in Urine by Screen method Nominal

114

720

1.61

5.39

1.8

2.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

210

1509

1.43

5.39

2.2

2.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

112

2.61

5.39

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

112

2.61

5.39

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

112

2.61

5.39

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

112

2.61

5.39

1.5

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

103

636

1.64

5.33

1.2

—

(3049717) Cytology report of Urine Cyto stain

130

851

1.56

5.28

2.8

2.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

303

2323

1.34

5.25

2.5

2.2

389.81

379.56

nmol/l

0.37

275

2165

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

102

631

1.64

5.24

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

115

733

1.60

5.24

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

241

1783

1.39

5.23

2.5

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

290

1.95

5.22

1.5

617.48

350.14

mu/l

0.91

234

(3051611) Lipemic interference index of Serum or Plasma

215

2.11

5.21

3.7

3.5

15.30

12.23

index

1.12

133

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

106

665

1.62

5.16

1.4

1.3

—

(3025941) Bacteria identified in Stool by Culture

178

1251

1.45

5.15

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

105

658

1.62

5.14

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

103

643

1.63

5.12

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.02

5.10

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

441

3577

1.28

5.07

2.1

2.2

29.98

29.61

0.45

428

3481

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.57

5.04

1.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

212

2.09

5.00

3.5

3.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

295

1.92

4.98

2.8

1.8

1520.00

1480.00

titre

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

121

793

1.55

4.91

3.3

3.0

24.28

24.80

mmol/l

1.18

121

780

(3036489) Thrombin time

136

915

1.51

4.90

1.9

2.3

20.75

20.86

0.13

123

821

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

811

9230

0.82

4.89

3.8

3.7

0.00

0.08

estimate

1.08

134

2141

(4198724) Urine methamphetamine measurement

101

2.59

4.80

1.2

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

107

688

1.58

4.73

1.2

74.55

101.01

titre

0.78

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

126

841

1.52

4.72

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

202

1479

1.40

4.68

2.4

1.9

—

(3002032) Base excess in Venous blood by calculation

299

2327

1.32

4.68

4.7

4.0

1.46

1.81

mmol/l

1.09

268

2001

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.72

4.68

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

572

6698

0.81

4.52

3.3

3.2

0.00

0.18

estimate

0.82

130

2059

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

103

664

1.57

4.52

1.2

1.1

4.21

3.55

0.24

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.87

4.49

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

150

1049

1.46

4.49

1.6

0.25

0.32

mg/l

0.99

491

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

350

1.79

4.48

1.1

2.73

3.22

—

(3022621) pH of Urine by Test strip

240

1822

1.35

4.46

2.3

2.4

6.08

6.09

0.09

152

1232

(3035637) Corticotropin [Mass/volume] in Plasma

315

1.83

4.42

1.5

1.6

41.96

27.90

ng/l

0.32

315

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

445

1.68

4.30

1.1

11.63

16.62

au/ml

0.29

117

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

114

2.38

4.23

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

102

2.47

4.21

45.9

40.0

7.39

7.18

ug/l

0.22

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

142

998

1.45

4.16

1.8

2.1

38.75

39.40

u/l

0.15

123

897

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

154

2.16

4.12

1.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

236

1.92

4.11

1.9

2.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

353

1.75

4.08

3.6

3.4

0.97

1.55

1.15

319

(3029937) Albumin [Presence] in Urine by Test strip

578

6702

0.82

4.07

4.2

3.9

0.00

estimate

1.34

175

2410

(40760892) CBC W Ordered Manual Differential panel - Blood

456

5408

0.81

4.02

5.2

4.7

—

(3035350) Ketones [Presence] in Urine by Test strip

1329

12242

1.17

4.01

4.0

3.8

0.00

3.01

estimate

1.59

187

2623

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

156

2.13

4.00

1.3

1.2

—

(3012544) pH of Venous blood

303

2417

1.29

3.97

4.8

4.0

7.37

7.38

1.76

160

1388

(3002256) Pathology report gross observation

379

3107

1.26

3.97

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

124

2.27

3.96

1.3

1.2

14.62

16.29

u/l

0.14

104

(3017354) Segmented neutrophils/Leukocytes in Blood

226

1.92

3.92

3.0

3.2

59.86

55.94

0.55

199

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

197

1486

1.35

3.84

2.6

3.6

4.46

4.53

pmol/l

0.47

172

1344

(3044927) Protein electrophoresis panel - Urine

221

1.92

3.82

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

140

2.16

3.77

1.8

1.4

1.59

1.27

nmol/l

0.48

107

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

200

1517

1.34

3.77

12.2

10.9

0.57

0.63

1.53

200

1507

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

127

2.22

3.76

1.3

1.2

70.68

80.57

u/l

0.45

108

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

106

719

1.49

3.75

2.1

2.7

190.28

187.79

0.11

101

691

(3021447) Carbon dioxide [Partial pressure] in Venous blood

299

2399

1.28

3.74

4.7

4.0

5.88

5.84

kpa

0.26

292

2333

(3009261) Glucose [Presence] in Urine by Test strip

1331

12305

1.17

3.73

4.0

3.8

0.16

0.13

estimate

0.05

173

2445

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.15

3.70

1.1

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.68

3.67

7.7

5.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.41

3.62

1.4

50.55

50.04

umol/l

0.01

(3003396) Base excess in Arterial blood by calculation

328

2675

1.26

3.59

9.2

8.6

0.57

0.88

mmol/l

0.73

278

2192

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.45

3.55

2.4

1.8

40.09

40.60

g/l

0.14

(3015171) Extractable nuclear Ab [Units/volume] in Serum

129

921

1.42

3.52

1.4

1.2

0.31

1.00

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

249

1968

1.29

3.52

2.3

12.24

13.00

nmol/l

0.68

209

1798

(3021601) Nitrite [Presence] in Urine by Test strip

1307

12100

1.16

3.51

4.0

3.8

0.00

estimate

0.80

187

2581

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

330

2702

1.25

3.49

9.2

8.7

5.23

5.10

kpa

1.64

320

2597

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.88

3.49

1.2

1.0

—

(3027801) Oxygen [Partial pressure] in Arterial blood

330

2703

1.25

3.48

9.2

8.7

11.71

12.40

kpa

1.79

321

2601

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

112

2.24

3.48

1.9

2.1

52.56

165.45

ug/min

—

(21494755) Public health laboratory ask at order entry panel

168

2216

0.74

3.48

1.4

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

203

1566

1.32

3.43

12.1

10.7

93.75

93.99

0.25

203

1558

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.35

3.41

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

2.25

3.38

1.1

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

120

2.18

3.38

10.1

6.3

41.50

39.91

u/ml

—

(3019977) pH of Arterial blood

328

2695

1.25

3.37

9.3

8.7

7.41

0.78

143

1464

(4015189) Microbial culture of sputum

2.84

3.35

1.5

2.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

210

1.87

3.35

4.3

5.5

89.97

51.85

u/ml

0.38

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

154

2.03

3.35

1.6

2.5

0.87

0.66

e9/l

1.50

148

(3003740) Influenza virus B Ag [Presence] in Specimen

462

1.57

3.31

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

463

1.57

3.29

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

219

1.84

3.27

1.2

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.59

3.26

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

234

1855

1.29

3.24

2.5

0.40

0.42

e6/l

0.08

221

1771

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

218

1713

1.30

3.23

3.4

3.1

171.80

188.16

ng/l

0.32

190

1559

(3022689) Creatine [Moles/volume] in Urine

2.59

3.21

1.6

8.24

9.38

mmol/l

0.32

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

304

1.69

3.15

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

111

2.17

3.12

1.6

3.2

126.89

131.41

umol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

181

1.89

3.05

3.5

3.3

92.63

35.63

mg/l

0.45

141

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

146

2.00

3.05

1.6

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

278

2271

1.25

3.02

3.4

4.3

13.40

21.99

ug/l

0.42

222

1842

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

200

1569

1.30

3.02

12.2

10.6

1.20

1.32

0.77

200

1558

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

166

1269

1.33

3.02

1.1

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

106

755

1.42

2.98

1.3

1.4

10.88

9.36

u/l

0.54

605

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

340

1.63

2.98

1.4

24.99

25.31

u/l

0.03

279

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.41

2.97

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

364

1.61

2.96

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

380

1.59

2.95

1.3

4.71

5.02

u/ml

0.08

174

(3024354) Oxygen [Partial pressure] in Venous blood

248

2008

1.26

2.92

3.6

3.4

4.80

4.55

kpa

1.24

239

1950

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

106

759

1.41

2.90

3.5

3.4

0.30

0.35

iu/ml

0.84

408

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

442

0.49

2.87

1.5

59.05

60.55

ug/l

0.07

442

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.68

2.87

1.0

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

275

1.68

2.84

2.3

2.4

2.20

1.26

g/24h

0.75

163

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

498

1.50

2.80

5.3

5.7

362.43

659.08

iu/ml

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

489

4256

1.18

2.80

3.6

3.2

0.76

0.75

ug/l

0.03

350

2768

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.09

2.77

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.09

2.77

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.09

2.77

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

517

1.48

2.74

1.1

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

214

1717

1.27

2.73

1.2

173.69

153.71

u/ml

0.25

662

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

601

1.45

2.71

1.1

22.46

5.53

eliau/ml

0.48

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

421

1.53

2.70

1.8

1.2

18.35

34.93

u/l

1.77

360

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.60

2.70

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

182

1.82

2.69

1.9

2.2

41.64

40.93

0.09

182

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.46

2.69

1.2

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

106

772

1.39

2.66

2.4

2.7

—

(3016502) Oxygen saturation in Arterial blood

290

2419

1.22

2.62

9.7

9.0

95.05

95.74

1.27

281

2337

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.55

2.61

1.1

1.3

115.83

85.19

ug/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

780

7072

1.15

2.60

5.8

5.5

2.07

2.95

ug/l

2.73

699

6421

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

691

1.40

2.59

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

3.06

2.56

1.3

2.0

—

(4035726) Immunohistochemistry procedure

237

1940

1.24

2.56

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

492

1.48

2.56

1.5

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

626

1.42

2.54

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

2.23

2.54

1.1

2.2

27.00

28.46

0.22

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

101

2.09

2.53

2.6

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.47

2.48

6.6

10.2

6.04

5.87

mmol/l

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

414

1.51

2.47

1.2

—

335.56

—

(3025130) Human papilloma virus identified in Specimen

390

1.52

2.46

2.1

1.9

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.67

2.45

1.9

2.1

2.81

1.48

mmol/l

—

(40768806) Pleura Pathology biopsy report

212

1.71

2.39

1.3

1.6

—

(4062490) Immunoglobulin typing, IgG

235

1.67

2.39

1.2

1.4

—

(3006245) CD3-CD19+ cells/cells in Blood

2.15

2.34

1.2

2.2

11.50

9.08

0.62

(3038177) Helicobacter pylori Ab [Presence] in Serum

388

1.51

2.31

1.3

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.19

2.31

1.1

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

126

1.91

2.30

5.3

7.4

923.69

157.82

ug/l

0.38

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

522

0.59

2.30

2.0

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

473

1.45

2.25

1.1

3.90

4.32

u/ml

0.07

262

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

616

1.39

2.24

1.8

2.3

11.92

11.39

mg/l

0.30

575

(3023199) Leukocytes [#/volume] in Pleural fluid

264

1.60

2.21

1.4

1.5

2473.73

5167.78

e6/l

0.36

181

(3019174) dRVVT (LA screen)

3.34

2.18

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

394

1.48

2.17

1.2

1.1

2.01

1482.99

iu/ml

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

646

1.37

2.16

1.9

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.78

2.13

2.1

1.5

—

(3008898) HLA-B27 [Presence]

114

873

1.32

2.13

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

182

1.71

2.11

3.9

2.6

24.88

34.11

mg/l

0.72

130

(3028308) Erythrocytes [#/volume] in Pleural fluid

228

1.63

2.11

1.4

35417.26

75897.70

e6/l

0.56

127

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

123

1.88

2.11

1.2

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

505

1.42

2.10

2.5

3.0

35.56

34.83

umol/l

0.11

458

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.91

2.07

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

415

1.46

2.06

1.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

627

0.65

2.05

3.3

4.2

3.95

3.89

mmol/l

0.70

620

(3021387) Prolactin [Units/volume] in Serum or Plasma

122

949

1.30

2.05

1.6

1.7

316.87

297.49

mu/l

0.30

114

860

(3016650) Hepatitis A virus Ab [Presence] in Serum

400

1.46

2.03

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

191

2308

0.81

2.03

3.4

3.3

—

(3014271) Vancomycin [Susceptibility]

2.06

2.01

3.5

2.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

612

1.37

2.01

1.3

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

753

1.33

1.96

1.8

1.9

43.10

40.78

nmol/l

0.40

731

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

100

763

1.32

1.94

1.5

18.04

10.21

iu/ml

0.15

119

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

4.55

1.94

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

330

1.49

1.94

2.1

2.3

6.47

6.88

umol/l

0.11

243

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.57

1.94

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

258

1.56

1.92

1.3

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

165

1.70

1.91

1.1

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

235

1.58

1.90

1.2

1.4

6.80

6.96

g/l

0.12

172

(3024139) IgG subclass 3 [Mass/volume] in Serum

235

1.58

1.90

1.2

1.4

0.34

0.40

g/l

0.71

172

(3028192) IgG subclass 2 [Mass/volume] in Serum

235

1.58

1.90

1.2

1.4

2.74

3.00

g/l

0.51

172

(3034092) Cytoplasmic Ig cells/cells in Blood

3.19

1.88

4.7

5.2

0.30

0.18

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

159

1.71

1.85

1.9

1.4

74.41

81.78

umol/l

1.05

159

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.40

1.85

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

122

1.81

1.84

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

562

0.65

1.83

1.3

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

393

1.43

1.82

1.2

2.27

4.27

u/ml

1.25

145

(4195642) Thrombophilia screening test

352

1.46

1.81

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

287

2483

1.18

1.80

5.2

6.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

292

2530

1.17

1.80

1.9

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

3.05

1.80

1.0

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.01

1.80

1.0

5.54

11.35

u/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

161

1.68

1.78

1.1

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

192

1.62

1.78

1.3

1.1

114.39

107.40

pmol/l

0.30

192

(3051387) C reactive protein [Mass/volume] in Capillary blood

461

0.62

1.77

3.6

3.7

20.13

26.28

mg/l

0.48

322

(3012441) Differential panel - Pleural fluid

224

1.57

1.76

1.4

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

124

1.78

1.76

1.3

1.4

5.96

5.13

umol/l

0.57

110

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

741

1.31

1.75

5.3

3.9

1.58

1.50

mg/l

0.35

680

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.03

1.75

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.03

1.75

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.03

1.75

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.03

1.75

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

201

1.60

1.74

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

201

1.60

1.74

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

201

1.60

1.74

1.5

1.6

—

(4268621) Lupus anticoagulant assay

274

1.50

1.71

2.2

2.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

735

1.30

1.71

2.4

2.8

3.86

3.60

g/l

0.83

700

(3051651) Icteric interference index of Serum or Plasma

133

1.74

1.70

4.3

3.6

0.57

0.92

index

1.81

133

(3042517) Benzodiazepines panel - Urine

3.16

1.66

1.3

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

103

810

1.28

1.65

1.6

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

461

1.38

1.65

1.0

1.1

1.69

1.16

u/ml

0.16

203

(3045683) HLA typing for celiac disease panel - Blood or Tissue

135

1.71

1.62

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

143

1.68

1.61

1.3

1.6

6.96

9.19

ug/l

0.59

126

(3000060) B lymphocytes [#/volume] in Blood

2.07

1.59

1.2

2.0

0.18

0.17

e9/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

542

1.34

1.58

1.2

1.1

0.74

2.71

u/ml

3.92

296

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

175

1.61

1.57

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

518

1.34

1.55

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

168

1.61

1.55

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

1.98

1.54

6.3

4.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

580

1.32

1.53

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1951

18986

1.11

1.53

26.3

19.9

331.95

332.47

g/l

1.82

1944

18881

(3016879) Cocaine [Presence] in Urine

117

945

1.25

1.52

1.6

2.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.34

1.52

1.4

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

104

829

1.27

1.52

1.3

225.52

221.49

miu/ml

0.04

397

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.86

1.50

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

105

839

1.26

1.50

1.5

1.3

—

(3000330) Specific gravity of Urine by Test strip

134

1102

1.23

1.49

3.5

3.3

1.02

ratio

1.33

118

1002

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

101

1.79

1.48

1.3

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

194

1.55

1.48

1.1

13.36

16.53

u/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.13

1.44

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.13

1.44

1.0

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

145

1208

1.21

1.43

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

616

1.29

1.39

1.4

1.5

0.98

0.95

ratio

0.23

378

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

616

1.29

1.39

1.4

1.5

1.21

1.18

ratio

0.13

378

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

616

1.29

1.39

1.4

1.5

1.36

1.14

ratio

0.73

378

(3017569) Oxygen content in Arterial blood

139

0.43

1.39

2.5

2.6

16.33

16.24

—

139

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.08

1.38

1.8

2.2

21.25

17.78

umol/l

0.42

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

299

0.60

1.37

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.94

1.36

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

120

1.67

1.34

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

120

1.67

1.34

1.4

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

155

1310

1.19

1.33

1.4

21.69

26.36

iu/l

1.14

129

1113

(3003434) Protein [Mass/volume] in Pleural fluid

291

1.42

1.32

1.4

1.5

31.84

31.96

g/l

0.02

262

(3023430) Cat dander IgE Ab [Units/volume] in Serum

368

1.37

1.31

1.0

1.1

7.72

5.51

u/ml

0.23

166

(3001019) Free T4 and TSH panel - Serum or Plasma

103

1259

0.81

1.30

1.8

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

117

965

1.22

1.30

2.2

2839.95

5683.47

u/l

0.83

392

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

211

1835

1.16

1.30

2.1

2.3

5.88

7.50

ug/l

0.98

171

1666

(1761482) Bacteria [#/volume] in Urine by Culture

485

0.70

1.30

6.1

4.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

137

1.61

1.29

2.2

2.8

41.82

40.48

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.36

1.29

1.3

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

161

1.56

1.28

1.4

1.5

21.60

21.81

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.09

1.27

1.2

1.1

1.19

mmol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

448

0.69

1.27

5.3

3.3

7.92

7.52

mmol/l

0.29

434

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.00

1.27

1.1

1.2

292.20

304.05

pmol/l

—

(44806420) Estimation of glomerular filtration rate

267

0.60

1.26

2.1

2.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

742

1.25

1.26

3.0

3.6

35.46

74.27

mg/l

1.08

637

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

608

1.27

1.25

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

662

1.26

1.25

3.2

3.4

1.49

3.37

ratio

1.43

380

(3010726) Horse dander IgE Ab [Units/volume] in Serum

450

1.32

1.24

1.1

1.83

1.55

u/ml

0.12

232

(3006922) Hepatitis E virus Ab [Presence] in Serum

187

1.50

1.24

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

287

1.40

1.23

1.1

1.4

0.19

0.24

nmol/l

0.42

226

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.91

1.22

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

330

1.37

1.22

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

279

1.40

1.22

1.1

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

138

1165

1.19

1.22

3.8

3.3

83.07

68.51

u/ml

0.17

130

1127

(3028300) Cannabinoids [Presence] in Urine

123

1029

1.20

1.6

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

122

1021

1.20

1.19

1.6

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

375

1.34

1.19

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

848

0.78

1.17

1.0

1.1

0.79

0.64

ratio

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

792

0.78

1.17

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

149

1.55

1.17

2.0

1.4

147.88

230.00

pmol/l

0.66

149

(3027008) Opiates [Presence] in Urine

122

1024

1.20

1.16

1.6

2.0

—

(3035715) Granulocytes [#/volume] in Blood

415

0.70

1.15

3.1

3.5

3.97

4.17

e9/l

0.20

415

(3034860) Kappa light chains.free [Mass/volume] in Serum

742

1.23

1.15

3.0

3.5

50.20

62.24

mg/l

0.40

636

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.15

1.0

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.50

1.15

1.8

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

199

1.46

1.14

1.3

1.5

1.24

1.16

promille

0.10

161

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

1.14

0.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

191

1.47

1.14

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

361

1.34

1.13

1.0

1.1

1.49

1.51

g/l

0.20

332

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.75

1.12

2.3

2.7

0.62

0.61

mmol/l

0.19

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

502

1.28

1.12

3.4

2.2

0.97

0.85

nmol/l

0.26

426

(3020891) Body temperature

1073

0.81

1.12

3.6

4.5

36.93

°c

0.00

1063

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

520

1.28

1.12

1.8

1.4

—

17.01

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

468

1.29

1.10

2.2

1.4

156.84

148.90

au/ml

0.21

140

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

251

1.40

1.10

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.38

1.09

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

1.09

1.9

2.9

10.52

10.17

kpa

0.14

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

1.09

1.9

2.9

4.84

4.94

kpa

0.22

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.19

1.08

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.12

1.05

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

911

0.81

1.05

1.1

1.55

1.54

g/l

0.13

911

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

187

1.45

1.03

2.1

1.9

—

(40757373) Influenza virus identified in Isolate

1.96

1.03

1.6

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.28

1.03

4.0

2.7

—

(3001556) Androgen free Index in Serum or Plasma

2.28

1.03

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

510

1.26

1.01

1.9

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1027

0.82

1.01

5.0

5.6

1.43

1.60

1.33

965

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

290

1.35

1.01

1.2

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.89

1.01

1.8

1.3

0.34

0.32

ug/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

205

1.42

1.00

3.1

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

403

0.72

1.00

1.4

1.3

—

9.43

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

574

1.24

1.00

2.0

1.9

181.14

206.06

pmol/l

1.05

548

(3052592) Norovirus Ag [Presence] in Stool

2.00

1.00

1.1

1.6

—

(3012501) Base excess in Blood by calculation

448

0.73

0.99

4.0

4.6

2.47

2.60

mmol/l

0.15

301

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

206

1.41

0.98

1.1

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

156

1.48

0.98

1.0

1.1

0.66

3.12

nmol/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

156

1.48

0.98

1.1

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

831

1.20

0.98

3.0

3.5

211.34

4838.34

u/ml

0.79

714

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.95

0.97

2.9

2.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

242

1.37

0.94

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.89

0.94

1.3

62.14

67.49

ug/l

—

(3035933) Granulocytes/Leukocytes in Blood

520

0.77

0.91

3.4

3.3

54.08

57.99

0.91

520

(3008295) Osmolality of Serum or Plasma

261

1.35

0.91

1.2

1.4

285.44

279.21

mosm/kgh2o

0.85

197

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

159

1.45

0.91

1.1

2.2

11.39

15.02

0.99

154

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

828

0.82

0.90

1.4

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.75

0.90

1.2

1.1

4.81

0.87

u/ml

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.07

0.89

1.8

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

1.49

0.89

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

0.58

0.88

1.4

—

(21494434) Karyotype in Bone marrow

211

1.38

0.88

1.3

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

217

0.64

0.87

1.5

2.1

19.78

19.85

nmol/l

0.01

204

(3014133) Dog dander IgE Ab [Units/volume] in Serum

396

1.27

0.86

1.1

7.53

4.34

u/ml

0.60

200

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

300

1.30

0.84

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

362

1.28

0.84

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

327

1.29

0.83

2.9

2.7

23.29

174.04

u/ml

0.64

322

(3027944) Amphetamines [Presence] in Urine

117

1016

1.16

0.81

1.6

1.9

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1926

18914

1.07

0.81

25.8

19.0

13.65

13.58

1.71

1911

18661

(3037756) Immunofixation for Serum or Plasma

463

1.24

0.81

1.3

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

232

1.34

0.81

1.6

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

106

914

1.17

0.81

1.9

2.14

1.81

ug/l

0.18

813

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

130

1.46

0.80

1.9

1.8

75.89

111.94

ng/l

1.88

130

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

609

1.20

0.80

1.5

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

347

1.27

0.80

1.0

1.1

2.48

0.22

u/ml

0.46

117

(3000093) Morphology [Interpretation] in Blood Narrative

207

1.36

0.79

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.79

0.0

1.3

—

5.90

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.82

0.79

1.0

1.4

9.94

5.31

nmol/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.67

0.78

1.3

1.4

—

166.29

—

(1617658) Protocol used for examination of sentinel lymph nodes

174

0.63

0.76

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

200

1.35

0.76

1.3

1.2

67.14

188.00

titre

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

670

1.18

0.74

1.4

1.5

60.81

60.49

ug/l

0.02

565

(3000285) Sodium [Moles/volume] in Blood

1.67

0.74

1.1

138.44

139.21

mmol/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.84

0.73

2.9

2.2

—

(1175426) CD3 cells/Lymphocytes in Blood

167

1.38

0.73

1.1

2.2

76.52

72.97

0.81

158

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

461

1.22

0.72

1.2

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.58

0.71

1.3

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

168

1.37

0.71

1.0

714.53

740.96

ng/l

0.11

106

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.75

0.71

1.6

10.64

246880.81

nmol/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

194

1.34

0.71

1.3

1.58

0.95

u/ml

0.21

100

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.92

0.70

1.6

2.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

177

1.36

0.70

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

101

1.49

0.70

1.4

6.2

46.90

65.47

mg/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

144

0.62

0.69

1.8

2.4

7.22

8.45

mmol/l

—

144

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.56

0.68

1.2

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.85

0.68

2.0

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

170

1.36

0.67

1.0

34.32

42.22

ng/l

0.70

106

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

330

1.25

0.66

1.2

1.1

7.08

2.68

eliau/ml

0.92

155

(4281824) Cell count and differential, peritoneal fluid

232

1.30

0.66

1.1

1.2

—

(3025159) Blasts/Leukocytes in Blood

188

2062

0.90

0.66

6.4

4.6

0.05

0.27

0.74

485

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

137

1.39

0.64

1.5

1.9

—

(3006653) Thiamine [Moles/volume] in Blood

137

1.39

0.64

1.6

1.3

132.26

135.92

nmol/l

0.13

137

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.73

0.64

1.0

1.1

0.03

0.02

u/ml

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.73

0.64

1.0

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

131

0.61

0.63

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

674

1.16

0.62

1.8

2.1

3.58

12.73

iu/l

0.55

274

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

103

909

1.14

0.62

1.6

1.8

3.73

4.83

mg/l

0.58

670

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.59

0.61

1.2

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.61

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

235

1.28

0.61

1.1

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

323

0.77

0.60

1.4

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

137

0.66

0.60

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.54

0.59

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

510

1.18

0.59

2.3

2.4

96.14

106.47

ug/min

0.08

321

(3023419) Bacteria identified in Sputum by Culture

318

1.23

0.58

2.9

2.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

641

1.16

0.58

1.2

1.3

471.12

526.26

mg/l

0.47

605

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.46

0.58

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

106

1.42

0.57

1.2

1.1

178.15

205.53

iu/ml

0.20

106

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

549

1.17

0.57

1.3

1.5

—

(3020650) Glucose [Presence] in Urine

0.57

0.56

2.0

1.9

0.00

0.07

estimate

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

172

0.70

0.56

1.5

1.6

—

(3011985) Renin [Units/volume] in Plasma

329

1.22

0.56

1.5

1.4

61.04

63.82

mu/l

0.03

297

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

627

1.15

0.54

1.5

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

169

1.30

0.53

1.0

268.12

304.25

ng/l

0.46

109

(3032773) Endomysium IgG Ab [Titer] in Serum

241

1.25

0.52

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

169

0.71

0.52

1.8

1.6

7.76

7.74

mmol/l

0.01

162

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.50

0.51

1.0

2.0

—

6592.86

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

1.35

0.51

1.0

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

261

1.23

0.49

1.2

1.6

57.75

60.54

0.13

166

(1616796) Gas panel - Central venous blood

496

0.84

0.48

4.8

4.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.45

0.48

2.0

1.5

13.82

13.88

pmol/l

0.03

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.49

0.47

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

429

1.17

0.47

1.5

1.4

64.29

63.54

mmol/l

0.04

353

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.41

0.47

1.3

1.2

—

(4034850) Laboratory test

686

0.87

0.46

11.1

9.7

—

(40758292) HTLV I+II Ab panel - Serum

1.43

0.46

1.3

1.4

—

(3018133) Calcium [Moles/volume] in Urine

1.43

0.46

1.6

2.7

2.85

2.93

mmol/l

—

(40768795) Lymph node Pathology biopsy report

209

0.76

0.45

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

516

1.15

0.44

1.4

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

383

0.83

0.43

1.4

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

257

1.21

0.43

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.61

0.43

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

387

1.17

0.42

2.3

2.1

4.11

5.04

mmol/24h

1.49

344

(3006462) Nitrate [Presence] in Urine

0.65

0.42

3.2

2.9

—

(3045788) Cell count panel - Pleural fluid

221

1.22

0.42

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

590

5702

1.04

0.41

4.4

4.5

22.78

21.64

0.91

278

2801

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.43

0.41

1.7

1.5

8.36

9.23

ug/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

284

2693

1.06

0.41

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.52

0.41

1.4

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

0.00

0.41

0.0

1.6

—

19.71

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

5.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.00

0.41

0.0

1.8

—

0.44

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3001729) Color of Synovial fluid

0.00

0.40

0.0

1.8

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

186

1986

0.93

0.40

1.7

3.48

3.45

mmol/l

0.10

133

1363

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.47

0.40

1.0

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

251

2652

0.94

0.40

2.0

3.62

3.45

ratio

1.16

197

2025

(3006184) Hemoglobin [Mass/volume] in Capillary blood

550

0.87

0.40

2.9

2.3

130.16

130.43

g/l

0.02

437

(3034891) Synovial lining cells/cells in Synovial fluid

105

0.67

0.39

1.3

1.4

—

4.55

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

203

0.79

0.38

1.2

1.5

27.75

31.43

—

127

(3004451) EKG impression Narrative

136

0.73

0.37

1.5

1.3

—

(3017181) Myelocytes/Leukocytes in Blood

200

2122

0.94

0.37

5.8

4.3

0.85

0.91

0.13

618

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

109

1183

0.92

0.37

1.5

1.6

902.76

1014.04

mu/l

0.77

995

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

1.27

0.37

1.1

—

(3034426) Prothrombin time (PT)

1.29

0.36

1.6

1.3

29.67

28.43

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

412

1.14

0.36

3.4

3.5

0.84

0.81

nmol/l

0.08

336

(3024932) HLA-DR beta [Type]

1.27

0.36

1.2

1.1

—

(3024471) HLA-A [Type]

1.27

0.36

1.0

—

(3005033) Fetal Nuchal fold Thickness US

507

1.13

0.36

1.4

1.5

1.28

0.01

366

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

145

1.24

0.33

1.0

1.1

0.91

1.10

u/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

127

1.26

0.33

1.4

2.9

511.00

1120.73

u/ml

1.95

127

(21494814) CD8 cells/Lymphocytes in Specimen

0.68

0.33

1.2

2.1

34.00

28.19

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

407

1.13

0.32

1.9

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

285

1.16

0.32

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

101

1.29

0.31

1.8

2.7

14.88

100.44

ug/l

0.54

(3024263) Appearance of Synovial fluid

110

1.27

0.31

1.8

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

513

1.11

0.31

1.7

1.3

220.86

247.67

u/ml

0.42

312

(3039443) Prostate specific Ag panel - Serum or Plasma

390

0.87

0.31

1.8

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

196

1860

1.06

0.31

4.0

2.7

71.26

68.48

ml/min/173m2

0.45

756

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.30

0.30

1.0

1.1

15.43

35.79

iu/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

765

1.09

0.29

1.6

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

148

1.22

0.29

1.0

25.49

0.94

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

431

1.12

0.28

1.4

0.40

0.41

nmol/l

0.02

333

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

386

0.88

0.28

1.4

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

116

0.78

0.27

1.3

1.2

12.89

9.22

mm/h

—

116

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

119

0.76

0.27

1.1

1.3

—

68.57

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.27

1.0

1.1

—

(4133840) Spirometry

1.23

0.27

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

529

1.10

0.26

1.4

1.6

—

(3045716) Anion gap in Serum or Plasma by calculation

257

0.85

0.26

4.1

3.4

9.68

10.63

mmol/l

0.68

252

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.69

0.26

1.0

1.1

—

15.29

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.67

0.25

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

559

1.09

0.25

1.2

1.4

16.51

39.47

e6/l

0.68

416

(3044007) Cell count panel - Peritoneal fluid

1.22

0.25

1.7

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.20

0.25

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

202

0.84

0.24

2.5

1.8

4.05

4.24

mg/l

0.08

195

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

407

1.11

0.24

1.6

1.7

—

(3021440) Promyelocytes/Leukocytes in Blood

195

2033

0.96

0.23

5.9

4.4

0.04

0.11

1.41

529

(3009871) Measles virus Ab [Titer] in Serum

0.75

0.22

1.7

1.6

—

3460.00

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.25

0.22

4.0

6.0

5.80

8.02

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.25

0.22

2.0

3.0

45.40

43.20

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

189

0.85

0.22

1.5

1.6

—

(3017704) Immunofixation for Urine

124

0.81

0.21

1.0

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.19

0.21

1.6

1.2

91.60

67.33

ug/l

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.21

0.0

1.0

—

18.40

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.90

—

(3002179) Metamyelocytes/Leukocytes in Blood

195

2027

0.96

0.21

5.3

4.2

0.46

0.69

1.81

584

(4038314) Semen analysis, post vasectomy

0.00

0.21

0.0

1.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

2.82

—

(4211845) Urine protein measurement

102

0.78

0.21

2.8

2.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

566

1.08

0.21

1.3

1.5

92.18

1013.09

e6/l

1.17

443

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.11

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3047181) Lactate [Moles/volume] in Blood

685

0.93

0.19

5.2

6.6

1.42

1.34

mmol/l

0.41

592

(40768800) Prostate Pathology biopsy report

453

1.08

0.18

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.73

0.17

1.0

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

148

1.15

0.17

1.2

0.60

0.56

ratio

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.18

0.16

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.16

0.16

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.13

0.16

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.10

0.15

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

468

1.07

0.15

1.5

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.10

0.15

1.2

108.11

106.14

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.80

0.14

1.0

1.5

0.46

0.50

e9/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.79

0.14

1.1

—

(44813793) Dust mix specific IgE antibody measurement

160

1.13

0.14

1.1

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.82

0.13

3.3

3.1

0.38

1.12

—

(3047189) Immunofixation for 24 hour Urine

107

0.84

0.13

1.7

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

201

1.10

0.11

3.2

3.8

19.62

64.62

u/ml

1.83

201

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

134

1.12

0.11

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

156

0.90

0.10

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

222

1.08

0.10

1.4

1.3

42852.40

115930.53

e6/l

0.81

149

(21491868) Cryoglobulin [Mass/volume] in Serum

1.13

0.09

1.0

1.2

—

0.06

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.09

0.08

9.3

5.6

20.97

25.56

mmol/l

—

(3003694) ABO and Rh group [Type] in Blood

683

6884

0.99

0.08

1.5

—

(40768793) Breast Pathology biopsy report

529

1.04

0.08

1.5

1.3

—

(3045142) Bone marrow Pathology biopsy report

266

0.94

0.07

1.4

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

176

1.08

0.07

1.4

2.1

0.75

1.63

u/field

—

104

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.06

0.07

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.02

0.07

1.2

1.6

50.67

471.77

nmol/24h

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

482

1.04

0.06

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

172

0.93

0.06

2.3

606.10

619.93

—

117

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

375

3722

1.01

0.04

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

322

0.96

0.04

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

322

0.96

0.04

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

322

0.96

0.04

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

322

0.96

0.04

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

101

1.09

0.04

3.1

4.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

141

1.06

0.03

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

538

5404

0.99

0.03

3.7

3.9

3.77

1.30

kg/l

0.43

368

3609

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

466

4680

0.99

0.03

1.7

45283422.52

32380176.27

pmol/l

0.16

371

3950

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

282

1.03

0.02

1.1

1.4

—

nmol/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

103

1.07

0.02

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

116

0.95

0.00

1.7

1.6

2.83

3.57

u/field

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

105

1.05

0.00

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

109

1.01

0.00

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

131

0.99

0.00

1.0

1.1

1760.22

1604.74

miu/ml

0.15

131

(21494890) Protein electrophoresis panel - 24 hour Urine

229

1.00

0.00

2.0

2.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

104

0.96

0.00

1.2

1.4

145.40

172.09

mmol/24h

—

104

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

136

1.03

0.00

1.5

1.7

1845.46

878.58

pmol/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

146

1.03

0.00

1.1

1.0

0.21

2.10

u/ml

—

(3042631) Mycobacterium sp identified in Specimen

297

1.01

0.00

2.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

147

1.02

0.00

1.6

1.5

—

(40765096) Chromosome analysis panel by Banding

0.89

0.00

1.0

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

-0.00

1.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.28

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

180

1.00

-0.00

1.2

1.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.3

—

16.23

—

(3028433) Virus identified in Specimen by Culture

0.87

-0.00

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.90

-0.00

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

28.11

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.02

-0.00

1.0

1.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

290

1.00

-0.00

1.4

1.6

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.3

—

378.57

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

4.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.89

-0.00

8.8

6.2

6.08

6.00

kpa

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.34

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.02

-0.00

3.0

1.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

342.78

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.02

-0.00

8.8

6.2

5.04

5.26

kpa

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_EXT_INFNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_EXT_INFNAS	1.229 [1.08, 1.4]	0.001
Birth year	0.996 [0.99, 1.0]	0.402

During the follow-up period (1.1.1998 — 31.12.2019), 922 out of 7274 females with H8_EXT_INFNAS died.

Males

Parameter	HR [95% CI]	p-value
H8_EXT_INFNAS	1.296 [1.15, 1.46]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 1222 out of 6899 males with H8_EXT_INFNAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_EXT_INFNAS.

N-year risk	Females	Males
1	0.084%	0.247%
5	0.761%	1.604%
10	1.791%	4.07%
15	3.653%	7.977%
20	6.526%	13.166%

Relationships between endpoints

↥

Index endpoint: H8_EXT_INFNAS – Other infective otitis externa

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other infective otitis externa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints